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ABSTRACT
Adherence to a prescribed medication regimen is often critical to successful disease
management. Cancer diagnoses often further complicate control of the comorbid diseases. Older
cancer patients with multiple comorbidities receiving chemotherapy treatment are at increased
risk for adverse health outcomes from uncontrolled disease when nonadherent to their
medication regimen. The intent of this pilot study was to test the validity of an evidence-based
screening instrument designed to identify patients at risk for medication nonadherence and
uncontrolled illness. The W-BMA (Washburn-Barrier to Medication Adherence) screening
criteria were applied to retrospective data of cancer patients with multiple co-morbidities. SPSS
was used to analyze the data using classification trees to compare the W-BMA screen with the
current screens used in the clinic alone. The W-BMA identified a significantly larger number of
patients with barriers than the current screens alone. Barriers found by the W-BMA screening
instrument are strongly related to uncontrolled illness, and, these barriers are often multi-layered,
impacting adherence and the health of the patient. Incidentally, there was strong evidence that
patients who have barriers addressed by oncology support services (nurse navigation and social
work) often fare much better than patients who do not. The instrument studied in this pilot
project requires additional analysis and refinement, however, there is strong evidence that proper
use of the W-BMA screening instrument used as part of a comprehensive medication adherence
program may improve adherence and lower risk of uncontrolled illness and adverse events.
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SECTION ONE: INTRODUCTION
Adherence to a prescribed medication regimen is often critical to successful disease
management. Non-communicable disease is expected to exceed 65% of the global burden of
disease in 2020; however, 50% to 60% of patients are nonadherent to their prescribed treatment
regimen (Lam & Fresco, 2015). Mental illness, diabetes mellitus type 2 (DM-2), cardiovascular
disease (CVD), and/or chronic obstructive pulmonary disease (COPD) are common comorbid
diseases seen with a primary diagnosis of cancer. Cancer diagnoses often further complicate
control of the comorbid diseases, due to the often-overwhelming nature of cancer and its
treatment on the patient and caregivers. Older cancer patients with multiple comorbidities
receiving chemotherapy treatment are at increased risk for adverse health outcomes from
uncontrolled disease when nonadherent to their medication regimen (Sarfati, Koczwara, &
Jackson, 2016).
The intent of this pilot study was to test the validity of an evidence-based screening
instrument designed to identify patients at risk for medication nonadherence and uncontrolled
illness. The goal was to compare the number of patients identified at risk with this instrument
with those identified by current screening methods for depression and distress alone, and to
assess the sensitivity of both methods. The Washburn-Barriers to Medication Adhere (W-BMA)
requires more time and attention than the current depression and distress screens. If an equivocal
number of patients can be initially identified without this instrument, there is no need to use it as
an initial screening method. Instead, patients could simply be identified by their high depression
or distress screening scores and then further evaluated at another time by the instrument being
studied. So, this author felt it was important to compare results of the W-BMA screen to the
current screening methods alone to ensure that it is a more reliable and sensitive instrument. The
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W-BMA screening criteria were applied to retrospective data of cancer patients with multiple
comorbidities. Addressing barriers to adherence can be complex and time-consuming for
healthcare providers, depending on the type, number, and extent of barriers present. Healthcare
providers around the country may not always have the needed evidence-based instruments and
support to address these barriers. The literature analyzed for this project contains clear evidence
that there are numerous barriers that are proven to impede adherence. Nonadherence that goes
unidentified, and is not adequately addressed, subsequently increases risk of uncontrolled illness
and adverse health outcomes to the patient (American Medical Association [AMA], 2018;
Centers for Disease Control and Prevention [CDC], 2017a).
An avoidable, adverse health outcome is not only detrimental to the patient, it also
infringes on the time and resources needed for ongoing scheduled patient care and reduces
reimbursement needed to help for efficient operation of the medical clinic. It is of growing
importance for healthcare providers and the healthcare system to be as successful as possible in
treating disease and managing health. In addition, The Joint Commission (TJC) and Centers for
Medicare and Medicaid Services (CMS) both expect healthcare providers to assess inpatient and
outpatient adherence to medication regimens and act on issues with adherence if possible (CDC,
2017a; Cawthorn, Mion, Willens, Roumie, & Kripilani, 2014). A formal, evidence-based process
to identify and address the most impactful barriers to medication adherence is needed to help
improve outcomes, reduce healthcare costs, and meet the expectations of regulatory and
accrediting agencies.
Healthcare providers and patients may benefit from development of an efficient and
effective evidence-based process to (a) identify signs of the most common, impactful barriers to
medication adherence; (b) identify applicable resources to address each of these barriers; and (c)
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consistently connect the patients to these resources. There is first, though, a need to develop a
valid instrument that will assist healthcare providers to identify the individuals that have
increased risk of adverse events from nonadherence to prescribed treatments. An instrument that
is valid will fulfill its intended purpose. This pilot study tested the validity of an evidence-based
screening instrument designed to screen individuals for potential barriers that are likely to
decrease adherence to their prescribed medication regimen.
Background
The World Health Organization’s (WHO, 2003) definition of adherence is “the extent to
which a person’s behavior corresponds with agreed recommendations from a healthcare
provider.” This definition includes the initiation, continuation, and discontinuation of therapy as
directed (Lam & Fresco, 2015; WHO, 2003). While working in the outpatient setting recently,
over a nine-year period, this researcher detected multiple complexities to medication adherence.
There are, in fact, as many as 42 significant specific barriers to medication adherence as detected
in one extensive meta-analysis of research (Irwin & Johnson, 2015). These barriers make
assisting patients with successful medication adherence very complex. In addition, it is very
apparent that there is currently little resource and time allocation for in-depth assessment of
barriers to successful home medication management in the typical clinical setting. This is by no
means unusual as healthcare settings of all types are pressed to be as efficient as possible when
providing patient care. Clinical staff are encumbered with many responsibilities with immediate
impact on patient care, and very reluctant to add tasks to their already busy day. Current
initiatives to address important patient safety metrics tend to be shadowed by priority tasks with
more immediate consequences. With these impediments, it is also likely that many barriers
remain undetected and unresolved.
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In considering prevention of nonadherence, one might ask if there is any benefit to
checking in with patients who are at lower risk of nonadherence to help keep them from
becoming nonadherant. Referral to the cancer support team is not likely necessary for those who
are already adhering to maintain adherence. According to Lafeuille et al (2016) a review of
Medicaid claims included 12,990 patients with schizophrenia age 25 to 64 on at least one
antipsychotic medication. Patients who showed adherence at baseline (regularly filled their
prescription) continued to remain adherent, especially when maintained on one simple regimen
and not switched (Lafeuille et al., 2016). It is more feasible and probably more impactful to
target those with a higher likelihood of medication nonadherence.
Impact of nonadherence. A CMS (2017a) report of national health expenditures for
2015 states that 324.6 billion dollars (10.1% of total United States health expenditures [CDC,
2017b]) was spent in that year alone on prescription drugs in the United States. Unfortunately,
only about one quarter of medications are taken as prescribed (AMA, 2018; CDC, 2017a; Lam &
Fresco, 2015). Various sources estimate that 50% to 70% of prescriptions make it to the
pharmacy, 48% to 66% come out of a pharmacy, 25% to 30% are taken properly, and only 15%
to 20% are refilled as prescribed (AMA, 2018; CDC, 2017a; Million Hearts, 2017). Patients who
are Medicare/Medicaid eligible with three or more comorbidities and receiving chemotherapy
are especially vulnerable to the consequences of nonadherence. Mental health and noncommunicable disease are expected to exceed 65% of the global burden of disease in 2020;
however, 50% to 60% of patients (especially those with chronic diseases) are nonadherant to the
medicine prescribed (Lam & Fresco, 2015).
Comorbidities in cancer patients account for inferior survival rates (especially in adults
diagnosed at an early age), poorer quality of life, and an increase in the cost of healthcare costs
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compared to patients without comorbidities (Sarfati et al., 2016). CMS is taking special note of
comorbidities previously not addressed during chart audits of its beneficiaries and TJC
inspections of accredited organizations. One example is a new measure for diabetes that
providers will be held accountable for and specifically examines adherence. One new measure is
NQF 2468: Adherence to Oral Diabetes Agents for Individuals with Diabetes Mellitus. CMS will
look at databases of individuals prescribed at least two oral diabetes agents in 12 months.
Specifically, they will look at adherence to the oral diabetes medications by checking if
prescriptions are filled. In addition, this measure is paired with two additional measures to check
adherence to statins and ACEIs and ARBs for individuals with diabetes (CMS, 2017).
Complexity of assessing barriers to adherence. There is great complexity in the
concept of addressing barriers to adherence in an efficient and effective manner in a busy
healthcare setting. Barriers may be numerous and intertwined in such a way that addressing a
single barrier does not improve adherence. Many published efforts to address barriers to
adherence discuss a single focus, such as literacy or reducing cost. At the University of
Pennsylvania and Pennsylvania Presbyterian hospitals, 1,084 adult patients were surveyed to
discover the issues they felt caused their readmission. The most common reasons included
feeling unprepared for discharge, trouble with accessing medications, and lack of social support.
Low socioeconomic status (Medicaid or uninsured) were more likely to report difficulty
understanding and executing discharge instructions and adhering to medication regimens
(Kangovi et al., 2012). In these examples, there may be many co-existing barriers that require
alleviating to ensure successful medication adherence.
Complications to addressing adherence arise from the patients and the providers. A study by
Flink & Ekstedt (2016) in Sweden examined the use of an education instrument that they hoped
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would be used by nursing staff to improve discharge teaching and medication compliance.
Information was given at discharge; however, the level of education provided was primarily
driven by the needs of the staff, as opposed to the patient's level of understanding. Although the
aim of the study was to see if the new instrument and process would improve adherence, it
proved to have no impact due to the time limitations of the nurses (Flink & Ekstedt, 2016). It is
very important to consider the feasibility of a process, as well as the culture of the setting, when
implementing a new practice. A multidisciplinary task force created an inpatient COPD pathway
(Brewer et al, 2016) which included standardized medication orders. Respiratory Therapists were
trained to follow the program which included discharge teaching and patient materials. The
Respiratory Therapists found that the primary medical team was unwilling to order specialty
service consults. The therapists also found that patients felt the reason they were readmitted is
that they felt they had been discharged too early on the previous admission. More data was
required to evaluate the effectiveness of their intervention.Similar experiences are common in
the local healthcare facilities as well, so any process implemented must be feasible and accepted
by those who are crucial to its implementation. Assessing if an intervention is feasible and
acceptable also requires examination of the available resources. An additional pharmacist-driven
study evaluated the impact of providing medications immediately upon discharge to patients
admitted to a psychiatric unit and found that this improved adherence to the treatment regimen
(Tomko et al., 2013). This type of intervention is only feasible when a dispensing pharmacy is
readily available.
Balling, Erstad, & Weibel (2015) report that the impact of pharmacist provided education
at patient discharge reduced readmission rates. In addition to 1,011 patients involved in the
study, 452 interventions were required by the pharmacist to intercept issues with the discharge
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medication list. Barriers to adherence can start in the clinic or hospital setting due to medication
reconciliation discrepancies (Balling, Erstad, & Weibel, 2015). Additionally, phone calls from
pharmacists have been shown to reduce rates of rehospitalizations of cancer patients when the
patients’ adherence was assessed, questions answered, and any discrepancies addressed within
30 days of discharge (Patel, Nguyen, Bachler, & Atkinson, 2017). Again, although these were
effective interventions, it is not feasible if it cannot be sustained. Pharmacy personnel in the
healthcare setting are rarely available for consistently making follow up phone calls, or
performing medication reconciliations.
To summarize the discussion of complexity, the feasibility of creating a new screening
instrument may be questioned due to the existence of current instruments that can be used to
assess medication adherence. One such questionnaire is called the 8-item Morisky Medication
Adherence Scale, which is a validated instrument used to assess patients’ medication taking
behavior and barriers to adherence. It is considered a highly reliable instrument in patients with
chronic diseases (Lam & Fresco, 2015). The scale is a patient questionnaire addressing
forgetfulness, or choosing not to take a medication; however, it does not screen for some
additional common impactful barriers such as financial constraints and educational barriers. It
also relies on the patient to provide thoughtful, honest answers. This may also prove to be
complex. To effectively impact adherence and reduce risk of uncontrolled illness with resulting
adverse medical events, the complexities of this problem must be addressed. Clinic staff must
have the time, support, and motivation to use a process consistently and as it is intended, for it to
have the best impact on outcomes.
Current efforts to address barriers to adherence. The retrospective data used in this
evidence-based research study was from records of patients treated at a local outpatient oncology
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clinic. The clinic is one of a few hundred in the nation to achieve recognition for their quality
care of oncology patients. Current quality assessments collected by the American Society of
Clinical Oncology’s (ASCO, 2016) Quality Oncology Practice Initiative report instrument
indicate that medication follow up falls somewhat below standards in many outpatient
institutions. CMS (2018) tracks outpatient quality measures, and according to their website, they
plan to begin focusing on patients receiving outpatient chemotherapy. The local oncology clinic
was involved in a pilot CMS program called the Oncology Care Model (CMS, n.d.). The
Oncology Clinic in which this project was completed is one of 191 current practices taking part
in the model. Patients who have had cancer treatment within 6 months and are eligible for
Medicare benefits are enrolled in the oncology care model (OCM) cohort at the Hematology
Oncology Clinic. The CMS expects OCM patients to receive enhanced services including care
coordination and improved care plans to help prevent emergency room visits and hospitalization
from the start of chemotherapy and for 6 months following a dose of chemotherapy. Barriers to
medication adherence may result in unnecessary emergency room visits and/or hospitalization.
There are many cancer care support system resources available, including navigators, social
workers, care coordinators, and others who are in a unique position to assist the patients.
However, like the vast numbers of care providers in the nation, they may not always have
awareness of some of the most impactful needs of the patient. The intent of this pilot study was
to test the validity of an evidence-based screening instrument intended to aid in identification of
the most impactful barriers that decrease adherence to prescribed medications. It is hoped that
reporting of this project creates awareness and an impetus for healthcare providers to screen for
barriers and partner with other professionals in healthcare and community resources to find
solutions to one of the most challenging patient care issues, medication adherence.
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Implications for practice. Comorbidities in cancer patients account for inferior survival
rates (especially in adults diagnosed at an early age), poorer quality of life, and an increase in the
cost of healthcare costs compared to patients without comorbidities (Sarfati et al., 2016). When
adding the consequences of nonadherence to the prescribed treatment regimen, the impact can be
devastating. Mausbach, Scwab, and Irwin (2015) and Sarfati et al. (2016) stated that nurses can
improve evidence-based practice guidelines for patients with comorbidities. This includes
guidelines to both identify and address barriers to medication adherence. In such, nurses at all
levels of practice can make a direct impact on mortality, cost of care, and quality of life
(American Association of Colleges of Nurses, 2006). The healthcare system both locally, and as
a whole, is impacted financially by medication nonadherence due to unplanned office visits,
emergency department visits, or hospitalizations (CMS, 2017a, 2017b). One or more factors may
comprise the barriers to adherence for a patient. These barriers may be intentional or
unintentional, intertwined or independent, and might include financial, psychological,
educational, medical, and behavioral components (AMA, 2018; Irwin & Johnson, 2015; ONS,
2016). Healthcare providers desire to understand how best to treat an individual’s medical
condition and deliver the best quality of care possible, while also working with healthcare
administration to provide this care as efficiently as possible. Understanding what barriers exist
for each patient that may prevent them from adhering to a prescribed treatment regimen is
necessary for tailoring a treatment plan. There must also be a connection made to the resources
that are available in answer to those barriers.
Problem Statement
Oncology healthcare providers and cancer care support staff currently lack a formal
evidence-based process to assess for the most common, impactful barriers to successful
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medication adherence. Medication non-adherence is especially impactful in older cancer patients
who have had cancer treatments. Individuals with warning signs of barriers to adherence may
benefit from a referral to a member of the cancer care services support team, such as a navigator.
Navigators and other support team personnel are currently available, and work with patients at
various stages in their cancer journey. However, there currently is no instrument for providers to
use for identification of the most common impactful barriers to care. Neither is there a
consistent, formal process to help connect these individuals to locally available, applicable
resources. A valid, evidence-based instrument to identify and address the most impactful barriers
to medication adherence may help improve outcomes, reduce healthcare costs, and help meet the
expectations of regulatory and accrediting agencies. Local healthcare providers do not currently
have a valid, efficient evidence-based process to (a) identify warning signs of the most common,
impactful barriers to medication adherence; (b) identify the applicable resources for each of these
barriers; and, (c) consistently connect the patients to available resources. Due to the complexities
of these steps, research must begin with a focus on the initial step of correctly identifying the
population at risk. This is a pilot study to test the validity of an evidence-based screening
instrument that identifies the most common, impactful barriers to medication adherence.
Purpose of the Project
The purpose of this study was to test the validity of an evidence-based instrument to
screen for the most common, impactful barriers to medication adherence and evaluate if it was a
more sensitive indicator of risk than the current screening methods alone. This instrument was
tested on retrospective data of high-risk oncology patients. The pilot study evaluated the validity
of the instrument, to see if it accurately identified CMS beneficiary cancer patients who had
barriers to medication adherence and as a result, were more likely to have uncontrolled illness.
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Patients who have some obvious warning signs of medication nonadherence, who are at high risk
for emergency room use and hospitalization are currently referred, on occasion, to navigators for
coordination of resource access and referral. It is hypothesized from information abstracted from
the literature review in this project, that increasing intervention efforts to eliminate certain
barriers to medication adherence will subsequently improve disease control, thus lowering the
potential risk of emergency room use and hospitalization. Currently, the only warning sign to
barriers for which referrals are consistently made, via use of validated instruments, is depression
and distress. While depression is a significant barrier, and distress may result in adherence issues
as well, they are not the only significant barriers found in literature. Oncology patients are also
initially referred to a financial counselor to discuss costs specific to their cancer treatment;
however, additional financial assistance may be needed further into the treatment period. Unless
the patient reaches out for assistance, this barrier may go undetected. Additional barriers
identified in the literature will benefit from intervention to help ensure that cancer patients
remain as healthy as possible during their cancer treatments and recovery.
The reliability of the test was evaluated as well. Specificity was tested by analyzing the
instrument’s ability to identify, not only an increased number of patients at risk compared to
informal referrals, but also whether or not the patients identified also have an increased
percentage of uncontrolled illness, so as to minimize false identification of patients who are not
at increased risk. For the instrument to be beneficial, it must not only correctly identify high-risk
individuals, it must also not falsely identify an unacceptable number of individuals who are not
truly at risk. This would make screening an unwieldy task that is too burdensome for the
healthcare system. There may need to be some alterations made to the instrument, and additional
future testing to ensure this is a useful instrument. The goal is to eventually introduce the
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assessment instrument into practice and increase referrals to navigators who then can coordinate
resources to assist patients with treatment adherence.
Clinical Question
In a one-year retrospective review of CMS eligible outpatient records, does the use of a
new evidence-based screening instrument developed from literature, compared to current
screening methods alone, increase identification of patients with barriers to medication
adherence?
SECTION TWO: LITERATURE REVIEW
Search Strategy
A search of CINAHL Plus with Full Text, Cochrane Library, JAMA, Journals@Ovid,
MEDLINE, MEDLINE with Full-Text (EBSCO), Nursing and Allied Health, and ProQuest was
completed. The keywords and Phrases used for the search included readmission,
rehospitalizations, cancer, oncology, diabetes type 2, depression, behavior, comorbidities,
medication(s), adherence, nonadherence, compliance, noncompliance, barriers, obstacles,
challenges, difficulties, issues, stigma, predictors, predicting, causes, drug therapy,
polypharmacy, prescriptions, providers, outcomes, quality of life, algorithm, toolkit,
questionnaire, assessment, instrument. Parameters of the search were journal articles published,
peer-reviewed, written in English with a focus on studies completed in the United States within
five years. Literature generally up to seven years were included if data used was not primarily
older than ten years. Additional searches were completed in the Liberty University Special
Collections database and on the websites of the Centers for Disease Control, Centers for
Medicare and Medicaid Services, Hospital Compare (Hospital Compare, n.d.), Kaiser Family
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Foundation, Oncology Nursing Society, American Medical Association, AHRQ, World Health
Organization, and the Patient Engagement Health Information Technology website.
Bibliographies were searched in articles and presentations for primary sources when
needed. Research articles, using data more than ten years old, were discarded as were articles
with insufficient data or concerning limitations. Also discarded were studies that identified
barriers, or interventions not supported by the preponderance of the literature. In some cases,
such as research on the impact of financial burden, literacy, and education on nonadherence,
there was such an overwhelming amount of evidence that only a limited number of articles on
those topics was retained and included. Melnyk Levels of Evidence was used to analyze the
literature used in this project and includes Levels 1 through 7 with Level 1 systematic reviews,
meta-analysis, meta-analysis with triangulation, clinical guidelines based on systematic reviews,
and meta-analysis were given the most credence when evaluating evidence for impact of barriers
and interventions. In all, 990 articles were reviewed and saved to EndNote for retrieval, while an
additional number of electronic databases and information retrieved from both paper and online
journals and textbooks were not counted. Out of those 990 research articles, 29 research articles
accompanied by 26 additional reliable sources of evidence were deemed to be applicable and
sufficient for creation of an evidence-based instrument for identifying potential adherence
barriers and increasing patient referrals to effective resources for adherence issues.
Critical Appraisal of Literature
Select resources used for instrument development. In researching various possible
resources to implement in the clinical setting, several helpful toolkits were analyzed. Each one
has been proven to be effective in its own way and for the purpose for which it was developed. A
universal precautions toolkit exists for addressing low literacy in the healthcare setting. This
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article (Weiss et al., 2016) emphasizes and recommends brown bag reviews of medication, as
opposed to review of electronic or printed medication lists, for accuracy of assessment to help
avoid issues caused by low literacy.
Routine medication reviews are completed regularly in clinical practice; however, it can
be difficult to get an accurate picture of adherence during a brief and usually verbal review of
medications. The “Universal Precautions” toolkit helps address literacy issues in medication
adherence (Weiss et al., 2016). In this research review, patients were encouraged to bring their
medications to the office so that a visual inspection could be performed. Bringing the
medications resulted in a doubling of the number of drug therapy problems identified, as well as
a doubling of the percentage of medication regimens revised. The office currently utilizes this for
all new patients, as well as any patients who may be having difficulty with their medications. Not
all physicians require this of all patients at every visit as suggested in this study.
The Oncology Nursing Society (ONS, 2016) developed an oral adherence toolkit with
several individual instruments that may help assess and improve adherence. ONS has provided a
similar toolkit for several years; the most recent updated in 2016. There are 13 individual
instruments within the toolkit that may be used for assessing adherence, identifying risk factors,
guiding patient education, identifying reimbursement and financial assistance resources,
identifying food, drug and pathway interactions, sample treatment tracking calendars, methods to
motivate, encourage, reconcile, and track medication adherence. In addition, there is an
instrument that can be used to track readiness to change. According to ONS, patients may be able
to provide their own warning of potential nonadherence by acknowledging they are not ready to
change which includes starting a new therapy. Lastly, there is a resource list for patients and
providers to aid in finding drug and cancer information, along with teaching materials from some
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of the most reliable resources on cancer and pharmaceuticals. The toolkit contains a list of 13
patient assistance and reimbursement resources for helping cancer patients afford their
medications. This toolkit contains very useful ideas for helping oncology nurses assist patients in
adhering to their medication regimens. As previously stated, it may be difficult for clinical nurses
to have the time to devote to the measures suggested in this toolkit. However, the individual
instruments are evidence-based methods of helping patients overcome barriers to adherence.
The AMA (2018) Stepsforward education material and toolkit provides an education with
CME credit available to healthcare providers along with a toolkit and support to help address
nonadherence issues in their practice. The AMA cites eight steps to addressing nonadherence: (1)
consider nonadherence first as the reason a patient’s condition is not under control because
“patients do not take their medications half the time” (par. 1); (2) develop a process for routinely
asking about medication adherence; (3) create a blame-free environment to discuss medications
with the patient; (4) identify why the patient is not taking their medication (eight common
reasons are cited including: fear, cost, misunderstanding, lack of symptoms, depression, too
many medications, worry, and mistrust); (5) respond positively and thank the patient for sharing
their behavior; (6) tailor the adherence solution to the individual patient; (7) involve the patient
in developing their treatment plan; and, (8) set up patients for success. The online education
module accompanying this toolkit has an excellent educational component that is very quick and
interesting to complete. It is a great guide in helping physicians and other healthcare
professionals in discussions with patients regarding adherence.
These toolkits provide helpful guidelines for addressing some of the barriers that exist to
medication adherence. An important emphasis is that of having an open and trusting relationship
with the patient, as well as time to have the discussion about possible barriers. These toolkits and
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guidelines are helpful for a focused subset of barriers and encouraging discussion; however, a
more comprehensive screening instrument accompanied by purposeful interventions organized
by dedicated staff may be more impactful in today’s very complex patients.
Appraisal of literature for categorized barriers. Following are five categories of
major adherence barriers, listed in order of impact, found in the literature to be the most
commonly reported, most potentially impactful, and most feasibly actionable, with the
accompanying research and comments.
Financial and social barriers. Cost can be a deterrent to filling prescriptions; patients do
not fill their prescriptions about a quarter of the time, and do not take them about half of the time
(AMA, 2018). Single marital status, lower income, and having more than 10 medications were
significantly associated with not filling medications. Reasons included cost by 23.5% of patients.
Additional reasons include lack of time to go to the pharmacy, medication not delivered or
dispensed, and inability to afford the medications (Wooldridge, Schnipper, Goggins, Dittus, &
Kripalani, 2016). Hanson, Habibi, Khamo, Abdou & Stubbings (2014) conducted a pharmacy
study to examine whether connecting patients with a team to help address the prohibitive
expense of multiple sclerosis drugs would improve adherence. It was in fact proven helpful,
although the team concept involving advanced providers was an expensive concept that would be
difficult to reproduce and sustain. The cancer center employs financial navigators, social
workers, and nurse navigators who may provide a more sustainable coordination of care.
Three major factors predict whether a patient can afford medication: (a) insurance
coverage, (b) overall health, and (c) income. In addition, individuals who make under $50,000 a
year in income are more likely to skip doses or stop taking their medication than individuals with
higher income (National Community Pharmacists Association [NCPA], 2013). In a New York
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Times online journal article, Frakt (2017) cited systematic reviews and randomized control trials
analyzing several methods to address adherence, such as electronic reminders, pill organizers,
and electronic reminder and feedback systems. The author concluded that reduced price, or free
medications, are the only consistent predictors that patients will take and refill medication as
directed: “For those with certain chronic conditions, extra help in affording medications can
reduce adverse events and hospitalizations” (Frakt, 2017).
One in five adults reported taking at least four prescription drugs with 55% taking at
least one. About 35% of patients taking four or more prescription pills reported taking lower
dosage or skipped doses (and, if uninsured did not fill the prescription) compared to 25% of
those taking three or fewer. Income of $40,000 a year or less was another predictive factor of
lowering, skipping, or not filling a prescription (Kaiser Family Foundation, 2017a). Roop and
Wu (2014) conducted an online survey of 5,000 oncology nurses. Of those nurses, 577 nurses
responded and 51% of the nurses worked in practices that had developed specific policies,
procedures, and resources for patients taking oral therapy. One of the most frequently identified
barriers to adherence was cost. Irwin and Johnson (2015) cited cost or lack of insurance coverage
was mentioned 26% of the time, and social support was a reported factor of nonadherence 32%
of the time in their meta-analysis of qualitative research with triangulation to quantitative studies.
At the University of Pennsylvania and Pennsylvania Presbyterian hospitals, 1,084 adults were
surveyed to discover the issues they felt caused their readmission. Among the most common
reasons included low socioeconomic status (Medicaid or uninsured) driven barriers of obtaining
and adhering to medication regimens (Kangovi et al., 2012).
Additional financial and social barriers include marital status and geography (where the
patient lives in relationship to healthcare and pharmacy). Single marital status is a significant
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predictor of nonadherence according to one study (Greer et al., 2016). Multimorbidity was
present in 36% of patients in a study of over 4,000 patients in the Netherlands by Aarts et al.,
(2015). In this review, low socioeconomic status was associated with increased comorbidities
(70% vs. 61%); cardio and cerebrovascular diseases negatively impacted survival. One-year
survival rate was 22% without comorbidity and 13% with Multimorbidity (Aarts et al., 2015).
Geography is a type of social barrier that can be a significant hindrance for patients who live in
rural areas, especially without reliable internet service (Heath, 2017).
Associated suggested warning signs. Financial and social warning signs include:
Uncontrolled illness; Unfilled prescriptions or refills; Pill bottle contains more pills than it
should based on fill date; Weekly pill container contains unopened days/unused pills; Patient
comments on cost of care or states “Trying to save money”; Self-reported absence of social
support; and Difficulty “getting into town” to make appointments (AMA, 2018; CDC, 2017a;
Greer et al., 2016; Heath, 2017).
Associated examples of recommendations/resources/expert advice supported by
literature.
Associated examples of recommendations, resources and expert advice supported by literature
include:
1. Consider lower cost medications (CDC, 2017a). Many methods of encouraging
adherence may lack sufficient data to prove efficacy. However, providing free or lowcost drugs is a well-supported, effective intervention (Frakt, 2017).
2. Referral to oncology nurse navigator for coordination of interventions and care:
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The patient may choose not to spend money on medications for many reasons.
However, if patient is eligible for assistance, explore whether patient knows about
available resources and understands how to utilize these resources.

•

If an employee, provide with the health network resource information through human
resources providing free financial counseling services.

•

Refer to oncology social worker and/or financial counselor. Often, these individuals
will access pharmaceutical, pharmacy, and laboratories that often have patient
assistance programs which many times can be located on their website or made
available by calling their main contact numbers. Patient may also need assistance
understanding Medicare/Medicaid benefits and services.

•

ONS (2016) Oral Adherence Toolkit contains a list of thirteen reimbursement and
patient assistance resources.

•

Consider living situation and location, access to transportation, fuel, and availability
of reliable internet and/or phone service before recommending services that require
travel or internet-based interventions such as telehealth classes.

•

Consider community health partnerships such as paramedic program to check on
health and well-being as well as home environment safety check (Heath, 2017).

•

There is not a one-size-fits-all method to encourage adherence, so it is important to
tailor each individual’s treatment plan to their needs to avoid waste. However, in all
cases, efforts to lower cost of medication for patients results in better adherence
according to the literature.

Depression/distress/anxiety. In a meta-analysis by Mausbach et al. (2015), over 17,000
women were evaluated for association of depression and adherence to oral anticancer therapy.
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Greater depression was in fact associated with lower adherence. This resulted in increased
mortality, increased medical costs, and worsened quality of life. Patients who are depressed or
anxious are less likely to take their medications (AMA, 2018). If a patient has a history of mental
health disorders, such as depression, anxiety, or addiction, he or she is less likely to adhere to
their medication regimen (Million Hearts, 2017).
Greer et al. (2016), in a systematic review of adherence to oral chemotherapy agents,
reported that depression played a significant role in nonadherence, with some rates dropping to
about 50% at the five-year follow up. Adjuvant endocrine therapy adherence was lower in
women with depressive symptoms, especially in younger women just starting endocrine therapy.
Individuals with depression have greater non-adherence than patients without depressive
symptoms. In this study, women with lower adherence were also found to have a shorter time to
recurrence of their cancer, increased medical costs and worsened quality of life (Bender et al,
2014; Mausbach et al., 2015). Long-term distress may be a predictor of non-adherence (Aikens,
Trivedi, Aron, & Piette, 2015).
Associated suggested warning signs. Associated suggested warning signs include:
Uncontrolled illness; PHQ-9 Depression screen Score of 15 or higher (Patient fills out PHQ-2
followed [if indicated] by the PHQ-9 questionnaire). A score of 15 or higher on PHQ-9 indicates
a moderately severe depression barring other causes such as thyroid disorder (Maurer, 2012);
NCCN Distress Score of 4 or higher; and Anxiety.
Associated examples of recommendations/resources/expert advice supported by
literature.
Associated examples of recommendations, resources, and expert advice supported by
literature include:
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1. Consider antidepressants. The AMA (2018) recommends treatment of depression to aid
in better adherence, and the ONS provides information gleaned from an extensive review
of literature on medication adherence. Treatment of depression is found to be an
intervention that is likely to be effective to increase adherence to prescribed treatments
(Spoelstra, & Sansoucie, 2015).
2. Referral to oncology nurse navigator for coordination of interventions and care:
•

Early treatment of depressive symptoms (Mausbach et al., 2015; Spoelstra &
Sansoucie, 2015).

•

Confirm that physician has been notified of PHQ-9 score of 15 or higher and consider
work up and/or referral to mental health professional.

•

Connect with family or social support

•

Healthcare institutions’ mental health web page often lists various resources for
support of depression and other mental health issues.
•

If employee, provide with resource information through human resource
partners to explore possible availability of free financial counseling services.

Medical. (Includes Side effects/Effectiveness/Medication Reconciliation
Issues/relationship with provider/multiple comorbidities/Polypharmacy) Murphy, Bartholomew,
Carpentier, Bluethmann, and Vernon (2012) reviewed 29 peer-reviewed primary studies of
female breast cancer survivors taking endocrine therapy published between 1998 and 2012.
Nonadherence rates were as high as 71% at five years. Factors in this category found worsened
adherence included older age and side effects. Although this study is older, it provides an
important level one review of data that is still applicable today and supported by additional
research, especially concerning older age and side effects. The previously mentioned study by
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Roop and Wu (2014) found that one of the most frequently identified barriers to adherence was
adverse effects of the medication.
The greater the number of different medications prescribed and the higher the frequency,
the more likely that a patient will be nonadherant to their medication regimen (AMA, 2018). The
relationship to the provider is also a predictive factor in adherence. “Mutually respectful
collaboration with providers” is one key to improving adherence (CDC, 2017a). A meta-analysis
of qualitative research with triangulation to quantitative research revealed a 42% frequency of
provider relationship as a predictor of adherence in the qualitative literature. A positive
relationship facilitates adherence while a negative relationship does the opposite (Irwin, &
Johnson, 2015).
Additionally, advertisements, news coverage, and stories can have a negative effect
and/or cause mistrust. Patients are less likely to fill their prescription if they do not trust the
prescriber (AMA, 2018). Side effects were also common reasons for stopping medication in 21%
of self-reported reasons for nonadherence in a national telephone survey of 1,020 adults with
chronic illness and four or more medications (NCPA, 2013). Side effects were found 40% of the
time in the qualitative literature in a meta-analysis of research regarding nonadherence (Irwin, &
Johnson, 2015). A qualitative study of Turkish migrants with type 2 diabetes found that
nonadherence may be impacted by different beliefs about medications (Peeters et al., 2015).
Barriers do not always originate with the patient. Barriers to adherence can start in the
clinic or hospital setting due to medication reconciliation discrepancies (Balling et al., 2015).
Although questionnaires can be time prohibitive to administer, some can be effective for
assessing nonadherence. Effective interviewing is an easy, low-cost method to assess a patient’s
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adherence. Although knowledge may not accurately reflect adherence, knowing that they will be
asked about medications by their provider may encourage adherence (Lam & Fresco, 2015).
As mentioned in the financial and social category, single marital status, lower income,
and having more than 10 medications were significantly associated with not filling medications.
Reasons included cost by 23.5% of patients. Additional reasons include lack of time to go to the
pharmacy, medication not delivered or dispensed, and inability to afford the medications
(Wooldridge et al., 2016).
Associated suggested warning signs. Associated suggested warning signs include:
Uncontrolled illness; lack of expected side effects; Distressed about side effects; prescription not
filled or refilled at expected rate; Late stage of cancer; Poor physical status; provider relationship
strained; no show for appointments and reluctance to reschedule; requesting a different provider;
patients’ significant other expresses concerns about patient not following treatment regimen
(AMA, 2018; CDC, 2017a; Irwin & Johnson, 2015; Verbrugghe, Verhaeghe, Lauwaert,
Beeckman, & Van Hecke, 2013).
Associated examples of recommendations/resources/expert advice supported by
literature.
Associated examples of recommendations, resources, and expert advice supported by
literature include:
1. Minimize side effects (CDC, 2017a).
2. Referral to oncology nurse navigator for coordination of interventions and care:
•

Follow up with phone calls to assess adherence, answer questions, and address any
discrepancies (Patel et al., 2017).

ADDRESSING BARRIERS TO ADHERENCE
•

35

Assess patients for possible perspectives of medication based on ethnic beliefs
(Peeters et al., 2015).

•

Consider motivational interviewing as opposed to traditional counseling to develop a
rapport with patient to enhance trust and adherence to prescribed therapies (ONS,
2016).

•

Encourage patients to stick with regimen for medications that tend to become more
tolerant over time.

•

Assess for medication reconciliation errors and drug-drug or drug-food interactions.

•

Some medications can be taken at bedtime to ensure that the period with most
prominent side effects occur during sleep.

•

Early follow up with medication reconciliation is important (Balling et al., 2015).

•

Follow up with patients who have missed follow up appointments

Behavioral/lifestyle. (Associated themes: Forgetting/Don't think it's needed/Didn't
"agree" to take it/Don't like taking it/ too busy/Away from home/no established routine).
Forgetting was the number one self-reported reason for nonadherence in a national telephone
survey (NCPA, 2013). However, additional research reviews of studies comparing reminder
methods to control groups revealed that this may not be as large of an impact as previously
reported (Frakt, 2017). Frequency of forgetfulness was 38% and doubting necessity was 35% in
a meta-analysis of research with triangulation (Irwin & Johnson, 2015). In the same study, pill
burden is mentioned with 25% frequency and regimen complexity 22% of the time.
As mentioned in the financial and social category, single marital status, lower income,
and having more than 10 medications were significantly associated with not filling medications.
Reasons included cost by 23.5% of patients. Patients who express that they are tired of taking
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medications are providing a warning sign that they are nonadherant (Million Hearts, 2017).
Additional reasons include lack of time to go to the pharmacy, medication not delivered or
dispensed, and inability to afford the medications (Wooldridge et al., 2016).
Associated suggested warning signs. Associated suggested warning signs include:
Uncontrolled illness; Prescription not refilled at expected intervals; Pill bottle contains more pills
than it should (check fill date); forgets; complains of being tired of taking medications, or too
many medications; weekly/daily pill box contains unopened/unused pills; reluctance to accept a
change in regimen; preference to be “prescription free” or “all natural” or other alternatives
(Irwin & Johnson, 2015; Million Hearts, 2017; NCPA, 2013; Wooldridge et al., 2013).
Associated examples of recommendations/resources/expert advice supported by
literature.
Associated examples of recommendations, resources, and expert advice supported by
literature include:
1. The S.I.M.P.L.E. method recommended by the Million Hearts (2017) program may help
improve adherence. S.I.M.P.L.E. stands for Simplify the regimen; Impart knowledge;
Modify the patients’ beliefs and behavior; Provide communication and trust; Leave the
bias; and Evaluate adherence (Million Hearts, 2017).
2. As previously mentioned, the study by Murphy et al. (2012) found factors such as
switching therapies to make regimens easier improve adherence, and behavioral factors
that improved therapy were referral and follow up by an oncologist for specific oncology
therapy; otherwise, patients tend to discontinue their oncology therapies earlier than
recommended.
3. Referral to oncology nurse navigator for coordination of interventions and care:
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Methods to encourage patient adherence recommended by ONS (2016) include
reminder instruments such as calendars, pill diaries, pill boxes with compartments for
time of day for each day of the week, electronic reminders such as alarms, timers,
smartphone apps, glowing or electronic pill containers, and medication dispensing
machines.

•

Involve support systems, encourage routines, review at each visit, and reminder calls
(CDC, 2017a).

•

Medication that requires taking with or without food or limits a food that is desired,
such as grapefruit, can deter adherence. Work with patient to find a compromise or
alternative therapy.

•

Taylor interventions to patient to assess methods of remembering medications. Try
less expensive methods first, such as a daily pill container, because more expensive
electronic reminders have not proven to make a more significant impact (Frakt,
2017).

•

Patient monitoring and multicomponent feedback such as blood pressure checks and
communication with provider office combined with education are most likely to be
effective for adherence especially as it relates to forgetting or ambivalence (Spoelstra,
& Sansoucie, 2015).

•

Patients most often forget their medications in the evening, weekends (especially
Sunday), and holidays. Encourage patients to use a consistent method to remember
medications even during these times that routine may change (Vervloet et al., 2013).
Examples of reminders that may help are combinations such as smartphone reminder
apps and travel cases for taking medication away from home.
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Educational. (knowledge deficits including general knowledge/limited English
proficiency/functional/Cognitive/Psychological limitation; also, Literacy/Health literacy/Vision
Impairment limiting ability to read educational materials/Memory
impairment/misconceptions/distrust) Education appears to be one of the most studied methods of
improving medication adherence. However, in relationship to the first four barriers above, the
impact of education is less supported by the literature discovered in this review. One can find
individual studies that support education and show limited improvement. However, it is
important to note that one-time education without additional support or follow up drops off in
effectiveness over time according to the literature.
Barthélémy et al. (2014) studied patient adherence to oral targeted therapies, hormonal
therapies, chemotherapies, and their attitudes, in a prospective study of 201 cancer patients.
Patients who took hormonal therapies for five or more years tended to drop off in adherence.
Patients were asked how well informed they felt about their therapy. The researchers concluded
that patients who were better informed had better adherence. The researchers concluded by
suggesting that better education and education repeated at intervals throughout the therapy time
period could be beneficial to increasing adherence to oral therapies of all types. This article
supports initial and ongoing education as an effective means of increasing medication adherence.
A randomized controlled trial conducted by Moss, Lowe, Frampton, and Revell (2014) of
45 hospitalized patients being discharged on warfarin were divided into two groups: one
receiving the usual care, and the other provided with structured counseling and an educational
video. Both groups were administered questionnaires at discharge and again at 3 months. Both
groups were also assessed for satisfaction and time in therapeutic INR. Patients who received the
intervention had significantly better knowledge of their therapy than the control group. In
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addition, they also reported improved satisfaction and better time in the target INR range. This
study suggests that a structured educational program at implementation of an oral medication
improves knowledge, satisfaction, and therapeutic benefits of the drug.
Predictors of nonadherence include limited English language proficiency, low literacy,
and patient states he/she does not believe in the benefits of medication or believes they are not
necessary or even harmful (Million Hearts, 2017). Patients who do not understand the purpose,
side effects, or expected time before it is effective may result in nonadherence. This is true in
patients with chronic illness because there is often no obvious result, so the patient may think it
is not doing anything for them and stop taking it (AMA, 2018). The ONS review of literature
recommendations suggest that in 2014 there was not enough information to establish education
as an effective means of promoting adherence (Spoelstra, & Sansoucie, 2015). However, an
additional study published by the ONS in 2015 cites medication knowledge was mentioned 25%
of the time as a barrier to adherence in an extensive meta-analysis of qualitative studies
triangulated with quantitative studies (Irwin & Johnson, 2015).
A TJC study (Cawthon, Mion, Willens, Roumie & Kripalani, 2014) assessing the
feasibility of a three-question literacy instrument states that addressing health literacy is a
national health priority, and Standard PC.02.02.01 is reflected in the statement suggesting that
the hospital effectively communicates to patients when providing care, treatment, and services
(par. 2). TJC defines health literacy as “the degree to which individuals have the capacity to
obtain, process, and understand basic health information and services needed to make
appropriate health decisions” (par. 1). It is a necessary skill for successful navigation of the
health care system, communication with providers, and management of chronic conditions.
However, an estimated 90 million adults in the United States have low health literacy which is
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associated with lower rates of preventive care, poorer disease control, and greater mortality, as
well as increased health care utilization and costs (Cawthon et al., 2014). Inability to read and
understand directions on pill bottle labels may be due to small print, confusing medical terms, or
abbreviations (CDC, 2017a). Patients with higher levels of education typically are correlated
with better health, have had more health education, and can advocate better for themselves
(Heath, 2017).
A structured, nurse-led teaching program that included follow-up phone calls at set
intervals had encouraging results in lung cancer patients taking an oral chemotherapy drug
(Boucher, Lucca, Hooper, Pedulla, & Berry, 2015). In a systematic review of randomized control
trials, it was proven that group psychoeducation was effective in improving medication
adherence in adults suffering from schizophrenia (Al-Batran, 2015). A study conducted by
pharmacists at MD Anderson Cancer Center in Texas showed reduced hospitalization when
patients were contacted by a pharmacist within 30 days of discharge to have adherence assessed,
questions answered, and any discrepancies addressed (Patel et al., 2017). An additional
pharmacist-driven study evaluated the impact of providing medications immediately upon
discharge to patients admitted to a psychiatric unit and found that this improved adherence to the
treatment regimen (Tomko et al., 2013). This is not feasible when a dispensing pharmacy is not
readily available. However, it may be helpful to utilize this method if available in the future.
To discover the issues they felt caused their readmission, 1,084 adult patients were
surveyed. The most common reasons included feeling unprepared for discharge and lack of
social support. Low socioeconomic status (Medicaid or uninsured) were more likely to report
difficulty understanding and executing discharge instructions (Kangovi et al., 2012).
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Associated suggested warning signs. Associated suggested warning signs include:
Uncontrolled illness; Reluctance, difficulty, or inability to read and/or understand pill bottle or
written instructions when asked; medication not taken correctly; calls pills by color, size, and
shape but cannot tell you what they are for; has not filled prescription; significant other takes
care of all paperwork, low socioeconomic status (AMA, 2018; CDC, 2017a; Irwin & Johnson,
2015).
Associated examples of recommendations/resources/expert advice supported by
literature.
Associated examples of recommendations, resources, and expert advice supported by
literature include:
1. Reduce complexity of regimen.
2. Referral to oncology nurse navigator for coordination of interventions and care:
•

Using fifth- to sixth-grade reading level with pictures and teach-back methods may
help patients feel better prepared for discharge and to care for themselves (Parr,
2017).

•

Consider referral for group psychoeducation for patients with diagnosed mental
illness.

•

Structured educational sessions and follow up calls (Boucher et al., 2015).

•

Ensure patient understands the benefits of adherence and harms of nonadherence,
involve support system, encourage routines, adherence instruments such as electronic
devices, and reminder calls (CDC, 2017a).

•

Use blister packs, pill boxes/containers separated by day of week and time of day,
request packaging and instructions with large font, provide instructions with large
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font in layman's terms at reading level fifth-grade or lower (CDC, 2017a; ONS,
2016).
•

Explore ways to provide medications immediately to patients when prescribed,
especially for those with psychiatric diagnoses (Tomko et al., 2013).

•

Early follow up with medication reconciliation important (Patel et al., 2017).

•

Surveillance for patients at risk to catch missed follow up appointments.

Conceptual Framework/Model
The Iowa Model (2015) provides the conceptual framework and direction for this project.
This model blends principles of frameworks including Transforming Care at the Bedside,
Transtheoretical Model, and Institute of Medicine (Hall & Roussel, 2014). The Iowa Model
provides a practical step-by-step guide for implementation of evidence-based projects from
identifying the trigger to disseminating the results. Working in a multidisciplinary clinic with
oncologists, advanced practice providers, and a large team of support personnel requires
consideration of the complexities of cancer care and thoughtful integration of any change into
practice, so that it is completed in an organized format (Hall & Roussel, 2014). The Iowa Model
framework provided the framework, and more specifically, provided direction when a
comprehensive instrument to screen for all of the primary barriers was not found.
This project utilized the Iowa Model (2015) identification of triggering issues and
opportunities to guide the project towards creation of an evidence-based instrument. As
evidenced by the literature discussed earlier, these triggering issues and opportunities are wellvalidated. As directed by the Iowa Model, a pilot study became the focus of this project and
creation of the instrument resulted. The instrument was studied in part to see if a practice change
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might be beneficial and feasible in the oncology clinic setting. It was decided to test the
instrument on retrospective data to help determine whether the instrument will work as desired,
to identify patients who are at increased risk for uncontrolled illness, emergency room visits, and
hospitalization. After the data was collected, and statistics were completed, the final steps in the
Iowa Model (2015) help to determine if a change is appropriate for adoption into practice.
Results show that this is in fact a feasible screening method, so next steps are to begin integrating
and sustaining the practice change and further refining the instrument. The instrument is the first
of three parts to addressing nonadherence (as mentioned previously), so in addition to
implementation, steps will need to be taken to help develop action plans for addressing each
barrier and tailoring interventions to the patient to aide in adherence.
Identifying issues such as the impact of medication nonadherence and the impact on the
clinic, accrediting agency requirements, and philosophy of care guided by the oncology
organizations such as ASCO and ONS guided the researcher to consider all of the implications of
a proposed research study. As a part of the process of working through the Iowa Model, there are
built in fail-safes to appropriately re-route the project and the efforts should it be needed. The
researcher must ensure that effort going into any project is a priority for the institution, that there
is sufficient evidence to conduct the project, and that the evidence will lead to an appropriate
change in practice. In addition to development of the instrument, a team is formed consisting of
OCM personnel, in particular the navigator who will be one of the primary individuals utilizing
the instrument should it be evidenced that it has significant usefulness.
The Iowa Model encourages, and accounts for, the interdisciplinary approach needed to
implement an evidence-based practice change. Interdisciplinary teamwork is a natural element of
cancer care which includes involvement of patients in the process, as seen in the Iowa Model
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revised June of 2015 (The Iowa Model Collaborative, 2017). The Iowa Model guides the
application of research to practice promoting increased quality of care (Mateo & Foreman,
2014).
Theoretical Framework
Theory of transitions. Theory of transitions provides the theoretical framework for this
project. Dr. Afaf Ibrahim Meleis’ theory of transitions provides a theoretical framework that
helps identify possible root causes for variables in expected behaviors, relationship among the
variables, and a framework for examining the outcomes (Im, 2013). Transitions occur when
people go through various stages and situations in life. These stages include developmental (e.g.,
adolescence to adulthood), situational (e.g., getting married or moving to a new neighborhood),
health/illness (e.g., diagnoses of cancer), and/or organizational types of changes (e.g., promotion
at work or taking on a new responsibility in the church) (Im, 2013). In addition to the change
itself, there are factors that can also influence how the person is impacted by the change such as
multiple changes at one time, the point in one’s life that the change occurs, or the awareness and
time span over which the change occurs (Im, 2013). The theory described by Im (2013) helps
explain why some people go through change well and others do not. The theory of transitions
may be very useful when examining the variables and their relationship to the ability of a person
to successfully transition to a state of accepting and successfully managing their disease(s).
Meleis began developing the theory of transition in the 1970s as she studied immigrant
populations and their health. The theory was developed from a borrowed sociology theory called
“Role Insufficiency Theory” (Im, 2013, p. 254). Meleis saw that immigrants often neglected
preventive health measures, such as preventive health screenings, due to lack of connection to
their surrounding new community. Immigrants often neglected health problems due to language
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barriers as well. In addition, they were often away from family and others that would normally
support them to seek healthcare. Role supplementation is one aspect of the role insufficiency
theory that Meleis stated can be provided by nurses. Nurses can play a role and step in
(supplement) where needed to provide education, support, and specific nursing interventions.
Meleis stated that the goal of healthy transition is “...the mastery of behaviors, sentiments, cues,
symbols associated with new roles and identities and nonproblematic processes” (as cited in Im,
2013, p. 255).
In the adult outpatient cancer clinic, individuals seeking cancer treatment come from all
walks of life, varying social circumstances, accompanying health conditions and behaviors, and a
wide range of accompanying cultural beliefs, attitudes, preparation, and knowledge. These are
known in this theory as transition conditions that can facilitate or inhibit transition during illness
(Im, 2013). Adherence to medication regimens, especially for those with cancer and
accompanying comorbidities, are especially at risk if they cannot successfully transition to a state
of successful adherence to the oncologists prescribed treatment regimen.
This theory will be helpful to inform why some patients may have a more difficult time
adjusting to a needed change, no matter how beneficial it might be. Nurses, especially nurses
practicing at an advanced level, can help patients transition by assessing a person’s readiness,
educating patients to help prepare and guide them, and providing role supplementation. Coaching
significant others is also an important skill of the advanced practitioner to guide them in role
supplementation when necessary to aid in transition from wellness, to a journey through illness
and either back to wellness, or to a new state of normal again (Meleis, 1975).
The Doctor of Nursing Practice (DNP) role is in a unique position to use the concepts of
this theory to inform an evidence-based project for the purpose of aiding patients to successfully
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transition to a state of medication adherence. In as much, this will help address one of the most
impactful challenges by those experiencing a new or existing cancer diagnosis. Recognizing and
appropriately addressing the various factors that play into a person’s successful transition to a
state of adherence from nonadherence is imperative for ensuring success of the project.
Summary
Implementation of an evidence-based screening instrument. There were no
instruments found in literature to assess for presence of the most common, impactful potential
barriers in a single, comprehensive format. As patients are moved quickly through a clinic
setting, this inability to efficiently screen for barriers and funnel to available resources such as
navigators, negatively impacts likelihood of adherence to prescribed medications in complex
patients with multiple comorbidities. Referral to healthcare personnel for intervention is key to
the success of the use of this instrument. The search for an organized referral method to ensure
that patients at high risk of uncontrolled illness and resultant adverse events such as
rehospitalizations, are provided with maximum available support services is not new or unusual.
A large healthcare organization in North Carolina is conducting a large study in 40 inpatient
units with a similar purpose (Duncan et al., 2017). Patients discharged home with stroke are
enrolled in a COMPASS Care plan that includes referral to a nurse who makes a phone call
within two days of discharge and sees the patient within two weeks. During the phone and inperson visit, the patient is assessed for social and functional determinants of health and provided
with an individualized care plan that includes utilizing community resources and planned follow
up. A secondary outcome of this study is medication adherence. The authors cited CMS as an
indication for devising better follow-up care of hospitalized patients. The study is ongoing
currently (Duncan et al., 2017). As posited earlier, an instrument to help healthcare workers to
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discover the full gamut and complexity of the barriers to adherence is essential before moving
forward with interventions.
To create an instrument that is as efficient and effective as possible at discovering
barriers, a multitude of evidence from research was used to organize the instrument into major
categories of barriers with warning signs to make assessment as efficient as possible. The
evidence was divided into similar categories, for identifying similar problems. There is some
slight overlap in some of the categories, and again, this only illustrates some of the complexity of
this task. In addition to categorizing barriers in an evidence-based fashion, accompanying
recommendations were added to help address each of the categories of barriers. The result is an
instrument with five categories of major adherence barriers found in the literature to be the most
commonly reported, most potentially impactful, and most feasibly actionable. Potential warning
signs of each of the barriers are listed to help alert healthcare personnel to further evaluate for a
barrier. This could be likened to symptom alerts for various medical conditions in that some
symptoms may occur with a variety of problems, but when further evaluated, a disease or
condition can be pinpointed and treated.
When combined with a robust patient navigator program and a variety of referral
resources, the screening instrument will assist healthcare personnel to refer patients for follow up
and intervention for their adherence barriers. The key to the effectiveness of this instrument as
supported by literature, is the mechanism for comprehensively identifying multiple, complex,
intertwining barriers and referring the patients to a navigator to coordinate needed interventions.
The desired result is to increase adherence, lower incidence of uncontrolled illness, and avoid
adverse events requiring emergency room visits and hospitalizations.
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SECTION THREE: METHODOLOGY
Design
This study was an evidence-based practice study utilizing the Iowa Model for EvidenceBased Practice. The Iowa Model guides the researcher to design and pilot a practice change
when sufficient evidence is available. Otherwise it directs to test a change in practice with a pilot
study (Iowa Model Collaborative, 2017). Due to inability to locate a comprehensive instrument
containing all of the major barriers identified in the literature, an instrument was developed using
the evidence found and a study conducted. The pilot study design was a retrospective, quasiexperimental, observational comparison study to evaluate the validity of a new evidence-based
screening instrument. Identification of barriers, interventions or potential interventions, and
ramifications such as uncontrolled illness, unplanned clinic visits, or emergency room visits, or
hospitalizations, were evaluated on the select group of patients. Patient data was evaluated to
determine what barriers were identified and if referrals were made using current methods. Next,
the instrument was applied to evaluate the same patients in this population to see if additional
barriers listed in the screening instrument were identified. Of those who had barriers according to
both the current and the new screening methods, there was an evaluation of sensitivity of the
screening methods by calculating the percentage of those patients who had uncontrolled illness
and/or events that might have been preventable.
The qualified CMS OCM patient population was chosen through a report run using
eligibility criteria described in setting and population. The identified population was further
analyzed for evidence-based warning signs of potential medication nonadherence using the new
evidence-based instrument. Within the subset of patients identified to have warning signs, it was
noted how many were referred to oncology support services for any of the existing applicable
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adherence warning signs such as depression, distress, or financial issues (following the initial
financial counseling appointment recommended to all newly diagnosed cancer patients).
There is future potential to also evaluate specificity of the instrument. Due to the
retrospective nature of this study, it was not possible to assess accurately for specificity, because
it was not the practice to assess and record every data point in the instrument. This was not
unexpected, because there was no formal process for collecting each one of the specific data
points in the instrument as it does not currently exist. False negatives in this study (patients who
had uncontrolled illness, but no barrier found in the medical record) could be attributed to the
fact that patients may have had barriers that simply were not detectable in the retrospective data.
Therefore, the primary objective in the data analysis following data collection, was to evaluate
the instrument for sensitivity alone, and note the limitations of the study for specificity. This
knowledge will be useful in discussion of the follow-up results as it relates to the risk for
uncontrolled illness and possibly increase in unplanned clinic visits, emergency room visits, and
hospitalizations or rehospitalizations.
At the time of the study, the clinic providing the retrospective data did not use a
screening instrument designed to assess for medication adherence, risks, barriers, uncontrolled
illness, adverse events, or otherwise. However, each patient prescribed chemotherapy treatment
was seen at least once for insurance and financial benefits investigation, and regularly screened
for depression using common depression and distress instruments. This researcher wanted to
evaluate if the more comprehensive screening instrument developed from literature for this study
would be more effective in identifying patients at risk for uncontrolled illness or if these existing
screening instruments could be coincidentally just as adequate. The dependent variable is
number of patients identified with barriers to medication adherence. Independent variables
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include previous identification of risk using depression and distress screening instruments alone
versus the new evidence-based toolkit containing five categorized barriers that include the scores
obtained on the current depression and distress screening instruments. The additional important
aspect of this study was to ensure good sensitivity of the new instrument. This was tested by
determining how many patients identified also had uncontrolled illness. An extra measure was
used in data evaluation to discover which barrier categories identified in this research had the
greatest impact on patients with uncontrolled illness.
Measurable Outcomes
Measurable outcome 1. A statistically significant increase in percentage of prevalence
of high-risk CMS OCM patients identified with potential actionable barriers to medication
adherence using the W-BMA screen compared to current screening methods alone.
Measurable outcome 2. Instrument sensitivity: Patients who are identified to be at risk
due to barriers found during W-BMA screening will have a significant incidence of uncontrolled
illness, making use of the instrument to help prevent uncontrolled illness and resulting risk of
adverse events worthwhile to the organization.
Setting
The retrospective data used for this study was from a local oncology clinic in Virginia. At
the time of the study, the clinic was involved in implementation of a system to become compliant
with new CMS standards related to the IOM’s 13 standards included in their report, Delivering
High-Quality Cancer Care: Charting a New Course for a System in Crisis (Institute of Medicine,
2013). This researcher discussed the study with some key stakeholders at the cancer center. The
consensus of leaders approached about this research topic was that it complemented the goals
and objectives that were currently in place to comply with the new quality standards for cancer
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care. The providers of the clinic were aware of the CMS OCM initiatives and the complexity of
meeting the goals. The key stakeholders at this clinic were seeking methods to address issues
such as medication adherence and decreasing emergency room visits and hospitalizations for
CMS OCM patients. They were very open to working with individuals, such as this researcher,
who might offer help and support. There was brief, yet crucial input provided by clinic staff to
help determine most appropriate population and population subset for this study. Clinic staff
assisted with providing the list of patients who met the criteria as well. The real time investment
will occur during possible future implementation and study of the W-BMA instrument; however,
the clinic has invested in a CMS OCM nurse navigator who is available to help support
implementation of the screening instrument, and to embrace a change that would help them
provide better care, improve quality scores, and decrease costs.
Population
This retrospective review of data included CMS patients enrolled in the OCM program at
a standalone community cancer center in Virginia. Located within two blocks, the community is
also served by an approximately 300-bed hospital which is designated a level-two trauma center
and part of a multi-facility healthcare system. At the time of this study, the two-story cancer
center contained an eight-physician medical oncology practice, infusion center, and clinical
research department on one floor, and on the other, a three-physician radiation oncology practice.
Administrative support services located in the cancer center included an oncology nurse
navigator team, social workers, dietician, nurse educator, and genetic counselor.
The cancer center participated in interdisciplinary comprehensive cancer conferences and
tumor board meetings and had been awarded quality program recognitions for oncology care and
various other programs for several years in a row. Patients enrolled in the OCM program at the
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cancer center are generally at least 65 years of age or older and have received cancer treatment
within the last 6 months. Patients over 65, especially those with multiple comorbidities, receiving
chemotherapy treatment are at increased risk for adverse health outcomes when nonadherent to
their treatment regimen (Sarfati et al., 2016). The qualified CMS OCM patient population was
chosen because of their vulnerability to adverse health outcomes and need for improved
medication adherence screening barriers.
Inclusion to the study required that patients had at least two visits within the previous
year, and that they were enrolled in the OCM program which indicates that they were Medicare
recipients and had received chemotherapy treatment. The sample was selected via a report
identifying those patients who were enrolled in the OCM program and had multiple visits within
the retrospective time frame. The researcher’s previous experience working with this patient
population, as well as the vulnerability of this population to adverse events from nonadherence,
combined with a setting in which the stakeholders are open to development and implementation
of a screening instrument, made this the ideal setting and population for this study.
There were 759 patients enrolled in the OCM program at the time of the random selection
for the study making up the population of focus for this research. The researcher requested that
the administrative personnel collecting the sample for the study select every third patient to
ensure a systematic sampling of the population. This sample was provided in the form of a list
which was kept locked to ensure privacy. The population sample studied included 250 OCM
patients treated and seen at the clinic at least twice in the previous year. Most of the population
was born between 1934 and 1950 with a mean, median, and mode of 1944. English was the
primary language spoken by almost 99% of the sample that included 119 male patients and 131
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females. The average number of prescribed medications in this sample was 10 with 10% taking
over 20 medications each.
The profile of a typical subject of this research, based on evaluation of findings, can be
described as a 74-year-old English-speaking woman living on social security with Medicare
insurance. She has been diagnosed with cancer within the last year and had chemotherapy
treatments, which may have been ongoing. She must return to the oncology office on a regular
basis for treatment and/or evaluation of adverse effects of the chemotherapy treatment and have
lab and radiology tests to evaluate for treatment effectiveness and recurrence of the cancer. In
addition to her cancer diagnoses, she has multiple comorbidities including DM-2, and HTN
which require that she see her general practitioner and possibly another specialist on a regular
basis. She has been prescribed about 10 medications that she must take on a daily or prn basis.
This number does not include any chemotherapy (intravenous or oral) or medications given in
conjunction with the chemotherapy to prevent adverse reactions or immediate side effects.
Neither does this number account for over-the-counter medications such as allergy or cold
remedies, sleep aides, pain relievers, vitamins, or herbal supplements. Her medication list that
she provides to the oncologist does not match what she provides to healthcare personnel as an
inpatient. She lives with her spouse and has a less-than-ideal physical status (ECOG 1) spending
a majority of the day sitting down or in bed due to not feeling well. Her blood glucoses are
typically elevated at each clinic visit. Multiple consecutive elevated blood pressure readings
indicate she may have uncontrolled stage two hypertension.
Ethical Considerations
Completion of Collaborative Institutional Training Initiative required training for
protection of human subjects (see Appendix C) by both the study chair and the researcher helped
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to ensure that ethical standards were upheld in the conduct of the research. The study was
approved by both the Institutional Review Boards (IRBs) of the university and the healthcare
institution. In addition, the study was reviewed by the Nursing Research Council of the
healthcare institution. A copy of approval letters are included in the appendices (see Appendix
F). As this is a retrospective chart review with collection of only de-identified data that cannot be
traced back to any individual patient and obtaining consent would create the only identifiable
attachment to the study, no consent was required. Although data will be de-identified, the key
and all sensitive patient information was kept secure in a locked office and/or on a secure
electronic file requiring a password and will be destroyed following completion of all research
surrounding this instrument.
Data Collection
The historical medical records of 250 OCM patients were reviewed one at a time using
the data collection instrument coded for use with the Statistical Package for the Social Sciences
(SPSS) analysis. This researcher extracted, recorded, and coded the data for this study. A data
collection sheet was used for each individual patient and later entered into SPSS. Two separate
electronic medical records (EMRs) were in existence at the time of the study. To ensure that all
applicable data was included, both EMRs were thoroughly reviewed.
After the patient identification code was transcribed to the data collection sheet, a note
was made of the patient’s year of birth and gender. Data was first reviewed for the presence of
PHQ-9 depression screen score of 15 or higher and an NCCN Distress score of 4 or higher.
Following that, it was noted if any interventions took place for the screening scores. This data
was recorded on the data collection sheet.
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Following a review of current screening methods, the researcher then analyzed the patient
record to extract warning signs as listed in the W-BMA screening instrument. The W-BMA
screening instrument includes the depression and distress screening results as part of the
comprehensive review of risk. Any warning sign found in the record resulted in a positive screen
for the category in which it applied. Also noted and recorded were applicable interventions, signs
and symptoms of uncontrolled illness, and unplanned healthcare visits. The primary purpose for
collecting the data in this manner was to collect the data needed to evaluate the desired
measurable outcomes for this study. First, to see if there was an increase in percentage of patients
identified with actionable barriers to medication adherence compared to those identified in
current screening methods alone. Second, to see if there is instrument sensitivity as predicted.
The secondary purpose for collecting this data in this manner was to evaluate the W-BMA
screening tool for future refinement and to learn from any incidental findings. SPSS coding was
performed as specified in Appendix G.
Instruments
An extensive search did not reveal an instrument that would efficiently and effectively
identify all the major barriers to adherence found in the literature review in an organized way. As
a result, this study became an evidence-based pilot study to evaluate an instrument that would
fulfill this purpose. To create an instrument that would be as efficient and effective as possible,
an extensive review of evidence from research was organized into major categories of barriers
with warning signs. The evidence was divided into similar categories with well-documented
research addressing each category. Over 40 barriers were identified; however, many of these
could be classified into a major barrier such as financial or medical. As a result, five major
barrier classifications with warning signs were developed, along with recommended strategies
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for addressing each category according to the literature found. The result is an instrument with
five categories of major adherence barriers found in the literature to be the most commonly
reported, most potentially impactful, and most feasibly actionable determined by the review of
literature and experience. Experience is an expected component of evidence-based practice but
was used cautiously in this study. Potential warning signs of each of the barriers are listed to help
alert healthcare personnel to a potential barrier. The literature review contains a detailed
description of the evidence used to support each of the five categories of barriers. The categories
of the W-BMA include Financial/Social Support, Depression/Distress/Anxiety, Medical Related,
Behavior/Lifestyle, and Education. The W-BMA was prepared with future dissemination in mind
and includes talking points and review of literature for each category for quick reference. See
Appendix D for the full four-page instrument. The basic W-BMA (Washburn_Barrier to
Medication Adherence Risk Assessment) Screening Instrument developed for data collection for
this study is pictured in Figure 1 on the next page.
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Barrier:

Warning Signs:
Financial/Social
Support

o
o
o
o
o

Depression/
Distress/
Anxiety

o

Medical Related
Concerns

o
o
o

Related cues: Side
effects/Effectiveness/Medica
tion Reconciliation
Issues/relationship with
provider/multiple
comorbidities/
Polypharmacy/ Poor
Performance Score
(ECOG)/cancer therapy last
6 months

o
o

o
o
o
o
o
o
o

Behavior/Lifestyle

o

Related cues:
Forgetting/Don't think it's
needed/Didn't "agree" to
take it/Don't like taking it/
too busy/Away from
home/no established routine

o
o
o
o
o
o

Educational
Related cues: Knowledge
deficits including general
knowledge/limited English
proficiency/functional/Cogn
itive/Psychological/Health
literacy/Vision
Impairment/Hard of
Hearing/Memory
impairment/misconceptions
/Distrust

o
o
o
o
o
o
o

Age 65 or higher and one or more of the
following:
Unmarried and/or absence of social support
Medicaid eligible
Income less than 50,000 dollars/year
Limited pharmacy access (location of
residence related to pharmacy, resides
outside of city, lack of transportation)
PHQ-9 Depression screen Score of 15 or
higher
NCCN Distress Score of 4 or higher
Diagnoses of anxiety, or on medication for
anxiety
More than 10 medications
Uncontrolled illness
Unexpected side effects and/or lack of
expected side effects
Distressed about side effects
Prescription not filled or refilled at expected
rate
Late stage of cancer
Poor physical status (ECOG 1 or over)
Provider relationship strained
No show for appointments and reluctance to
reschedule/Requesting a different provider
Significant other concerns about not
following treatment regimen
Prescription not refilled at expected
intervals
Pill bottle contains more pills than it should
based on fill date (If it is the original bottle)
Taking additional unprescribed herbal or
"natural" substances
Tobacco, ETOH abuse, illegal drug use
Weekly/daily pill box contains
unopened/unused pills
Reluctance to accept a change in regimen
Preference to be "prescription free" or "all
natural" or other alternatives
English is not first language
Reluctance, difficulty, or inability to read
and/or correctly explain written medication
instructions (on pill bottle or med list)
Medication not taken correctly
Identifies medications by color, size, and
shape but unable to explain what
medications are, or what they are for.
Has not filled prescription/reluctant to
answer questions about compliance with
regimen
Significant other takes care of all paperwork
Known memory impairment

57
Notes:
(referrals/interventions)

Record # of meds
here:______
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Illness:
Diabetes
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Signs/Symptoms:

Related Medication if
applicable:

Sign/Symptom/Diagnoses

Related medication if
applicable

Hypertension/
CVD
Renal
Impairment
Sustained
uncontrolled
depression or
Mental Illness
COPD/
Asthma
Unplanned Care:
Clinic Visit
Emergency
Room Visit
Hospitalization
Note if support services were involved throughout the retrospective service dates yes/no
Figure 1. Washburn_Barrier to Medication Adherence Screening Instrument. Copyright 2018
The W-BMA instrument, along with the methods for data collection and data analysis
were reviewed by both university and healthcare IRBs as part of the study approval process and
approved for data collection for this study. For data analysis of the first outcome, the information
was grouped into one dependent variable—number of patients detected by the instruments in
question, and two independent variables—number of patients with high depression and/or
distress score known as current screen and number of patients with at least one of the five
barriers known as W-BMA instrument or W-BMA screen. For data analysis of the second
outcome, any one or more types of incidences of uncontrolled illness was recorded as an event
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for sensitivity and specificity tests. Although there were no expectations that all warning signs
would be evident in the process of data collection, the education barrier category and clinic visit
category were both difficult to assess with confidence. However, even though there was not
enough evidence to factor these into data collection, leaving education in the barrier assessment
category is supported by literature and leaving clinic visits in the assessment for adverse events
may be useful for future testing of financial impact.
Intervention
An extensive, comprehensive literature review was completed in 2017 and early 2018
followed by development of the W-BMA instrument. The healthcare professionals assigned to
work with OCM patients were consulted for feasibility input and to discuss a method of
collecting a systematic patient sample. IRB approval was requested in late March and obtained in
June 2018. Data collection was immediately started, following obtaining the list of sample
patients from the quality coordinator. The qualified CMS OCM patient population was
identified, and the retrospective chart review completed at the end of July 2018. The data
extracted from the record was coded and entered into SPSS. A statistician was consulted in midAugust, and in mid-September of 2018 analysis was completed which then allowed for recording
of the results of the retrospective study in this paper.
Feasibility Analysis
This study was feasible in that it required very limited initial resource of time, not more
than one hour from two specific healthcare personnel dedicated to this population to provide
input into instrument feasibility as well as the patient sample list. Approximately half a ream of
paper was utilized for 250 printed data collection instruments. The time needed to conduct the

ADDRESSING BARRIERS TO ADHERENCE

60

study fit within the available dedicated DNP practicum time of the researcher, thus no salary was
required for the majority of work done on the study.
Data Analysis
The Iowa Model Collaborative (2017) directs to use a pilot study when implementing
evidence into practice. This plus using retrospective data, was important when testing the
validity of this newly developed instrument. This pilot evidence-based practice research study
included a systematically chosen sample of OCM patients and examination of retrospective data
from their records for up to one year before IRB approval between June 1st, 2017 and May 31st,
2018. This research focused on two measurable outcomes to pilot an evaluation of the validity of
the W-BMA instrument. This instrument was compared to existing screening methods alone to
rule out the possibility that it is as effective in identifying patients at risk for nonadherence and
resulting uncontrolled illness. All statistical analysis on this data was completed using IBM SPSS
Statistics for windows vs. 25 (IBM Corp, 2017). The sample was chosen to ensure a 95% to 99%
confidence interval with 1% to 5% margin of error. Specific tests were performed to evaluate
each outcome; however, a statistician was consulted, and a classification tree recommended to
assess independent variables that were the most impactful in patients with uncontrolled illness as
found in the retrospective data. The classification tree was useful in incorporating the intent of
this screening instrument into a visual useful in ongoing evaluations, and possible future
development of a guide to prioritization of barrier interventions.
For SPSS analysis purposes, the researcher coded data as described in Appendix G. Data
was grouped and coded to transform data into dichotomous output and entered into SPSS in
separate variable fields used to perform the statistical tests. The uncontrolled event fields were
recorded as either yes (1) there was an uncontrolled illness of some type, or no (2) there was no
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uncontrolled illness found for that patient. The data used specifically for each measurable
outcome was coded in a similar fashion as described below. This provided simple nominal data
for use with the statistical tests.
Measurable outcome 1. The first measurable outcome of interest was to evaluate
whether there was a statistically significant increase in percentage of prevalence of high-risk
CMS OCM patients identified with potential actionable barriers to medication adherence
compared to current screening methods alone. Data collected on the current screening
instruments was coded to indicate the result, whether the screen was found to be positive or
negative for a risk factor. If either the current depression and/or distress screening instruments
was found to be abnormal, this was recorded as a positive result for the independent variable of
current screening methods. Yes (1) if positive and if within normal range, a no (2) for negative
was recorded for that variable. The same method was carried out with the second independent
variable, the W-BMA screening instrument. The patients’ records were further evaluated for all
five categories of risk, and if there was at least one barrier found, it was recorded as a positive
finding. If any one of the five major barrier categories were marked as positive (meaning
warning signs of a barrier existed) the variable was marked yes (1) or if none were found it was
marked no (2) for negative.
The hypothesis was that the W-BMA screen would identify more people at risk for
nonadherence than the current screening method alone. To evaluate the data, a paired T-test was
planned first to compare the population before and after application of the new screening
instrument. A paired T-test is used for comparison when two different methods of measurement
are applied to the same subjects (Mathematics Learning Support Centre, n.d.). Although a T-test
might be used due to the nominal or dichotomous variables (Sullivan, 2017). The test was not
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appropriate here partially due to the distribution of data before and after the instrument was
applied. A normal distribution is required for accurate results in this test. To evaluate whether the
results disproved the null hypothesis that the current depression and distress screening method
will be as effective in identifying patients at risk for nonadherence as the new screening
instrument, a simple frequencies table was produced in SPSS.
Measurable outcome 2. Instrument sensitivity: The hypothesis of this outcome is that
patients who are identified to be at risk due to barriers found during retrospective screening will
also have a significant incidence of uncontrolled illness. As a result, it is hoped that investing the
time to use the W-BMA instrument to proactively help prevent uncontrolled illness and resulting
risk of adverse events will be worthwhile to the organization. Sullivan (2017) states that
screening tests are not for the purpose of making a medical diagnoses. They are intended to
identify individuals most at risk.
Although sensitivity testing was easily applied to these study results, specificity was
evaluated, but not significant in this study because of the retrospective nature of the study. False
negatives (patients who had uncontrolled illness and/or adverse events but no identified barriers)
in this study could be attributed to the fact that patients may have had barriers that simply were
not detectable in the retrospective data. Further research is needed to evaluate instrument
specificity.
SECTION FOUR: RESULTS
Descriptive Statistics
This was a retrospective, quasi-experimental, observational, comparison pilot study using
three statistical tests on dichotomous data. A sample of 250 out of a population of 759 patients
was systematically selected for improved probability sampling. Frequencies run in SPSS
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provided information on difference between the number of patients identified with potential
actionable barriers to medication adherence using the W-BMA screen (97.6% [86.0% with
associated medication]) compared to current screening methods alone (28.4%).
Next, a sensitivity and specificity tests were analyzed for the second hypothesis to
evaluate if the instrument was correctly identifying patients at risk for uncontrolled illness.
Patients with any identified risk factors were evaluated for uncontrolled illness. In previous
discussion, it was established that specificity testing was not feasible for this retrospective data.
Sensitivity test resulted in 83.2% of patients identified with barriers had an uncontrolled illness
and 86.2% of patients with barriers had uncontrolled illness related to a prescribed medication.
Classification tree results were as follows: 184 out of 250 (73.6%) of W-BMA screened
patients had uncontrolled illness or events consisting of extra clinic visits, emergency room
visits, or hospitalizations. Of those patients, 82.8% had barriers in the category of medical related
concerns undetected with current screen methods and had uncontrolled illness. For those patients
either without barriers, or whose medical related barriers were fully addressed by a healthcare
worker, 34% had uncontrolled illness. The Chi-square test imbedded in the classification tree
results is indicative that the variables are in fact dependent.
Of interest, notice again the less-than-ideal specificity, indicated below in Figure 2,
probably primarily due to use of retrospective data. The W-BMA instrument includes warning
signs that are not always historically recorded, so where W-BMA results were negative for
barriers, there may in fact be a barrier leading to the uncontrolled illness. This is where
additional study of the W-BMA instrument may be beneficial. In patients where the W-BMA
instrument identified behavior and lifestyle concerns undetected by current screening, 80% (P <
.0009) of those individuals had uncontrolled illness or events.
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Figure 2. Classification tree: Patients with uncontrolled illness or event(s).
To further evaluate the impact of barriers found by the W-BMA instrument, over half
(56.6%) of the time, uncontrolled illness was found in patients prescribed a medication for their
illness. Of those patients for which medication was prescribed, 62.0% (P < .0002) had undetected
medical related barriers using current screening methods. These patients had incidence of
uncontrolled illness, despite having a medication prescribed for that illness. From the original
(56.6%) group of patients with uncontrolled illness related to medication prescriptions, 29.0% (P
< .0002) of those individuals had barriers detected and addressed, yet still had incidence of
uncontrolled illness. These patients also had behavior and lifestyle concerns which went
undetected in four out of nine patients resulting in an 80.0% incidence of uncontrolled illness
when not detected and addressed.
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Figure 3. Classification tree: Patients with uncontrolled illness or event(s) and related prescribed
medication.
The data in the classification trees described above contains some very positive
information of note. In several cases, the data shows the impact made by the oncology healthcare
staff. When oncology service nurse navigators, social workers, or others intervened to address
barriers, there was a clear reduction in uncontrolled illness or events. For example, in the first
classification tree, Figure 2, when medical or behavior/lifestyle concerns were detected and
addressed by these individuals, there was no uncontrolled illness or events 66.0% and 100.0% of
the time respectively. Likewise, in the second classification tree, Figure 3, for the same barriers,
patients with related medications who maintained controlled and out of the emergency room and
hospital were 71.0% and approximately 80.8% respectively.
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SECTION FIVE: DISCUSSION
Implication for Practice
Currently there are many published toolkits available for use in healthcare settings. In
addition, one can search literature and find a multitude of research on barriers to adherence, and
interventions proven to have an impact on adherence and illness control. However, what is not
found, is a comprehensive evidence-based instrument to screen for the most common, impactful
barriers to medication adherence. Introducing the use of a comprehensive risk assessment tool
such as the W-BMA instrument into practice is a first step in developing a comprehensive
program to remove medication adherence barriers. Removing barriers to medication adherence
may result in better controlled illness and reduced healthcare costs.
This research study included a pilot, or test-run, of the W-BMA screening instrument in
retrospective data of OCM cancer patients. Despite the use of retrospective data, the new
evidence-based instrument was found to be a more sensitive detector of potentially impactful and
actionable barriers than the combined use of the PHQ-9 depression and NCCN distress screening
instruments alone. This was an important question to answer, because although depression and
distress impact many facets of a person’s life, nonadherence can be complex, multifaceted, and
require intervention of more than one form. Healthcare professionals may have erroneous
notions that nonadherence is rare, misunderstand the barriers that make a patient nonadherent,
and misunderstand the typical profile of a nonadherent patient. This may result in overlooking
many nonadherent patients daily.
One lesson learned in this research involved observation of a high percentage of patients
with uncontrolled illness. Nonadherence to medication regimens due primarily to the barriers
listed in the screening tool may be a primary reason for these observances. Any question about
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how common nonadherence is in the general population can be answered with the evidence from
the aforementioned literature estimating that 50% to 70% of prescriptions make it to the
pharmacy, 48% to 66% come out of a pharmacy, 25% to 30% are taken properly, and only 15%
to 20% are refilled as prescribed (AMA, 2018; CDC, 2017a; Million Hearts, 2017). The findings
of this study and incidence of uncontrolled illness in the sample, combined with the evidence
from literature, creates a strong argument that nonadherence to medication regimens in these
patients is likely related to the uncontrolled illness.
The SPSS frequencies analysis was conducted to compare the W-BMA screen with the
current screens alone. The results suggest that the W-BMA really does identify a significantly
larger number of patients with barriers than the current screens alone. The null hypothesis
“Current screening methods alone identify a similar number of “at-risk” patients as the W-BMA
screening method”, however, the W-BMA screen identified more at-risk patients, allowing
rejection of this null hypothesis. A significant number of patients in the sample size had barriers
that went undetected by the healthcare clinic probably due to a lack of screening methods for
these barriers. The significance of this finding was revealed in the classification tree produced in
consultation with a statistician. The classification tree and sensitivity test shows evidence that
first, the barriers found by the W-BMA screening instrument are strongly related to uncontrolled
illness and second, illustrates how barriers can be complex and multi-layered so that even if one
barrier is addressed, there may be others that significantly impact adherence and the health of the
patient.
The use of retrospective data aided in accomplishing this pilot study without risk to the
population to which it was applied. This researcher gained valuable insight into the potential use
of the instrument in practice, especially as part of a disease or population specific intervention
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program. Patient navigators, social workers, case managers, clinical nurse specialists, nurse
practitioners, and patient educators working with populations at risk may find benefit in
implementing this comprehensive screening instrument. The information derived from this pilot
test did not in itself validate the instrument. Much of the validation has been derived from the
copious amounts of fine work done by hundreds of individuals to resolve this very complex issue
as demonstrated in the existing literature. Much of this available literature is outlined in
Appendix A and discussed in the literature review.
A benefit of a pilot study is the ability for researchers to make improvements in the
design of the study through lessons learned. Many ideas look great on paper, but seeing them in
action allows researchers to gain a realistic perspective and identify the limitations and design
flaws. This helps ensure success and efficiency of the larger study. Much of the validity of this
instrument comes from the literature, but validity and feasibility of application of the instrument
for practice must be assessed as evidence-based practice studies in each unique setting for which
application is desired. The W-BMA instrument was developed with the structure and resources
of the local cancer center in mind. The cancer center and associated healthcare system employs
navigators and other staff who have the expertise and resources to intervene for some of the most
vulnerable of the population as a part of a comprehensive navigation program. This research did
not focus specifically on the impact of navigation or social work; however, the results of this
study, especially as seen in the classification trees, indicate that these services do play an
important role in promoting the well-being of vulnerable patient populations. Having this
instrument available as a resource to help detect more impactful barriers may result in a lower
rate of uncontrolled illness and adverse events.
Limitations

ADDRESSING BARRIERS TO ADHERENCE

69

This research study had several limitations, many of those are intrinsic to pilot studies
involving untested processes or procedures. However, there are those that warrant discussion to
inform for future research on this instrument and warn those who may be tempted to use the
instrument in practice without further study. Following are some of the limitations most
impactful to this research study and worthwhile noting for future research using this instrument.
One limitation of this study involved the availability of data due to the retrospective
design. The statistical tests used combined both categories of current, and all five categories of
the W-BMA screening instruments, into one variable. However, not all warning signs, or even all
categories of the W-BMA, could be assessed on retrospective data. Many of the individual data
points in each category are not typically assessed and recorded in a normal clinic setting. This
limited the ability to test for specificity of the instrument. The education barrier category and
clinic visit category were both difficult to assess with confidence due to available documentation.
There were not enough results from those single categories to report any meaningful findings as
an independent variable. However, leaving education in the barrier assessment category is
supported by literature and leaving clinic visits in the assessment for adverse events may be
useful for future testing for financial impact. Prospective studies that include purposeful
collection of all data points would help provide a robust evaluation of the W-BMA instrument.
Subject demographics aside from general population information, were limited to gender
and age. Race was not recorded and is an important consideration in future analysis of this
instrument. In the population studied, the race most common to the population is known to be
Caucasian, which mirrors the population treated as a whole at the cancer center. It may be
beneficial to include race in the demographics of future studies, especially in locations where
there is a more diverse mix of patient race. Additional demographics may be helpful including
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income level, zip code, transportation, employment, and specific social support (marital status)
available to the patient.
Uncontrolled illness was used to test sensitivity; however, this assumes that the
uncontrolled illnesses were caused by medication nonadherence or were somehow directly
related. The classification tree arranges specific W-BMA barriers according to prevalence in the
subset of patients with uncontrolled illness. However, there may be additional barriers,
undetected in the data that would be more impactful to the patients’ ability to adhere to their
medication regimen. A prospective study in which each barrier category is thoroughly assessed
would help eliminate this limitation. In addition, a prospective study may also help correlate
medication nonadherence to the barriers and uncontrolled illnesses, although the literature makes
a strong case to prove a hypothesis of that nature.
Another limitation is that the W-BMA instrument is a new screening instrument only
tested by this single pilot study in a very specific population rife with medical comorbidities.
Uncontrolled illness in this population may be much more common than in other populations,
making the sensitivity testing for this group not applicable to other groups of patients. More
testing is needed to validate the screening instrument in other populations to evaluate
effectiveness at detecting preventable barriers and improving adherence. As noted in the
introduction, research shows that people who are already adherent are very likely to stay
adherent. This helps to conclude that future research may best be focused on populations that
tend to have difficulty with medication adherence, multiple comorbidities, and uncontrolled
illness. Although the screening instrument was created from research that proved there is a
significant association of these barriers to uncontrolled illness, it is still an assumption that likely
requires further testing.
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Finally, the sample was selected in a manner to eliminate sample bias; however, the
researcher then collected, coded, and entered the data into SPSS. Having an independent person
code the data for preparation of entry into SPSS is normally recommended to help ensure good
coding practices are used, and researcher bias is avoided. This researcher hopes to further
explore the use of this instrument in additional vulnerable populations, avoiding some of the
limitations discussed here.
Sustainability
Adherence to a medication regimen is often a complex issue that requires thoughtful
consideration and sustained intervention at the micro, mezzo, and macro levels. The use of the
W-BMA screening instrument will be sustained if properly used and integrated into a larger
comprehensive program. The micro level will be sustained through thoughtful use and
interpretation of the instrument by the health professionals working with the patient. At the
mezzo level, the health professional must engage with local, organizational groups such as
palliative care teams, and resources such as navigators, social work, educators, advanced practice
nurses, pharmacists, and others to develop a team approach to address barriers for each patient.
The macro level requires that the entire community become engaged in supporting patients with
adherence issues on a long-term basis. Examples of community programs that can help sustain
interventions include community paramedic programs and reduced medication cost programs.
Sustainability for the W-BMA screening instrument will require that it be used as a part of a
comprehensive program at all three levels for identification of, and intervention for barriers.
The environment in which this study took place is a very supportive environment in
which innovative improvements in practice are encouraged. Healthcare professionals and
administration work tirelessly to improve the entire oncology populations’ healthcare outcomes
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and quality of life. The cancer center employs a team of healthcare professionals that include
disease and population specific navigators, including an OCM navigator, as well as other integral
support professionals such as social workers and educators. These individuals may utilize the WBMA instrument for a full evaluation of patients in this population. Clinic physicians, nurses and
staff simply do not have the time to complete the full evaluation required for best use of the
instrument. Any attempt to integrate full screening at this level is not sustainable. However, a
referral may be quickly made to a navigator when any number of barriers are identified by clinic
staff. In certain populations, such as the one studied here, patients are automatically referred to a
navigator at which time the instrument can be fully utilized.
Attempts to implement the instrument into an EMR for use on a wider patient population
is something that could be examined in the future after further refining and study. This could be
implemented in such a way that identification of a warning sign such as uncontrolled illness, or a
high distress screening score would trigger a referral for further evaluation. Future use of the tool
may include referral of additional populations of patients in the practice, generated from
inpatient, or outpatient physicians, nurses and other healthcare professionals by simply
identifying warning signs in one of the barriers.
The instrument studied in this project requires additional analysis and refinement before
full implementation; however, the healthcare professionals involved with the population studied
are very open to change and adoption of new methods or technology. It appears that addition of
this screening may enhance the excellent services provided to the patients under their care. The
key to sustainability for this screening instrument is in the methods used to glean the needed
information from the patients, and then identifying, prioritizing, and adopting the appropriate
interventions for each of the barriers found.
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An important aspect of sustainability is correct use and interpretation of the instrument.
One must be able to prioritize the barriers with consideration that resolving one barrier may also
help resolve other dependent barriers, because attempting resolution of a barrier that is dependent
on resolution of a more impactful barrier could be futile. Such futility would create an illusion of
instrument ineffectiveness and discourage continued use. Continued use of the instrument may
be influenced by measurable improvements in adherence to prescribed medications with reduced
incidence of uncontrolled illness. Healthcare professionals utilizing this instrument will need to
have access to the resources required, use critical thinking to prioritize the interventions needed,
and implement them in a way that is sustainable for these patients who often have very complex
barriers.
Dissemination Plan
The bible provided much of the inspiration for this researcher when developing and
researching the W-BMA instrument and planning for dissemination. Isaiah 43:19 states,
“Behold, I will do a new thing; now it shall spring forth; shall ye not know it? I will even make a
way in the wilderness, and rivers in the desert” (King James Version). Healthcare professionals’
(this researcher included) begin to raise their threshold of what is acceptable in the way of
nonadherent behavior and uncontrolled illness, as it becomes more and more prevalent. Perhaps
this happens very slowly over a period of several years in a healthcare system serving patients
with increasingly complex intertwining factors, including more pressing healthcare issues such
as cancer. Another contributing factor may also be that comorbid illnesses are often managed by
multiple, loosely connected healthcare teams.
After nine years of work in oncology clinical research, this author learned that evaluating
medication adherence, working closely with all healthcare teams involved in the care of the
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patient’s comorbid conditions, and intervening to remove barriers to adherence, increases a
patient’s likelihood of adherence to their medication regimens and lowers their likelihood of
uncontrolled illness and resulting adverse events. This researcher also observed the effectiveness
of a navigation program for patients with complex illnesses managed by multiple systems and
teams. With this background in mind and with support from oncology clinic administration and
support team, this project was undertaken to develop an instrument that might help improve
OCM patients’ adherence and lower incidence of uncontrolled illness. Dissemination of the
knowledge learned in this research will be accompanied by a word of caution that it was a pilot
project requiring more study, but with great hope that it will eventually improve the health and
welfare of some of the most vulnerable cancer patients, and eventually other populations as well.
The Iowa Model provides a practical step-by-step model to guide implementation of evidencebased projects from identifying the trigger to disseminating the results. Dissemination will take
place in multiple formats following the Iowa Model “Implementation Strategies for EvidenceBased Practice” (Cullen & Adams, 2012).
Although patients are the focus of this evidence-based screening intervention, the target
of dissemination will be the healthcare professionals and administration who will integrate this
instrument into a comprehensive medication adherence program for their patient population.
Methods to disseminate this information will include poster presentations, podium presentations,
and publication of a manuscript based on this project, preferably to a journal of nursing specific
to oncology nursing. Organizational support will be guided by the Iowa Implementation Model
beginning with education about these research findings and recommendations for further
research on the use of this instrument in a prospective manner. This researcher will also upload
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this project to Liberty University Scholars Crossing where it can be accessed through the worldwide web.
This evidence-based research study invites a plethora of new collaborative research by
nursing and other healthcare team members. The use of the instrument requires study to further
assess feasibility of use in busy cancer centers. Can this instrument also be used in at-risk clinics
for other acute or chronic disease states, or even the patient who returns repeatedly to the
emergency room for treatment of uncontrolled chronic illness like diabetes? Evidence-based
practice requires input and agreement from three sources for success: literature, healthcare
providers, and patients. This study presents a resource that is validated with literature, pilot
tested in one local population, and now needs to be tested and critiqued by healthcare providers
in other communities and populations. Patients need to be approached with this screening in a
manner that encourages open and honest participation, a challenge when working with people
who often do not feel well and move quickly through their clinic visits.
In addition, there is a need to evaluate the impact of barriers and prioritization of
interventions. The research found in this project was very informative for addressing individual
barriers, but how is this applied to complex patients with multi-layered barriers? As indicated by
the classification trees, individuals are still at risk when there are underlying issues. How does
the healthcare community come together to ensure a sustainable practice of identifying these
vulnerable patients and interceding to remove all impactful barriers, improve adherence, and
measure resulting impact to the healthcare system? As a healthcare system, effort must be made
to improve adherence to medication regimens and reduce the incidence of uncontrolled illness in
our most vulnerable patient populations.
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“And let us not be weary in well doing for in due season we shall reap, if we faint not.”
Galatians 6:9 (KJV)
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APPENDIX A: Evidence Table

Name: Addressing Barriers to Medication Adherence: An Evidence-Based Screening Instrument Validation Study
Clinical Question: In a one-year retrospective review of CMS eligible outpatient records, does the use of a new evidence-based
screening instrument developed from literature, compared to current screening methods, increase identification of patients with
barriers to medication adherence?

Article Title,
Author

Al-Batran, M.
(2015).
Evidence based
practice: The
effectiveness of
group
psychoeducatio
n for
medications
adherence
among inpatient
adults with
schizophrenia in
psychiatric and
mental health
settings. Middle
East Journal of
Nursing, 9(2),
25-30.

Study Purpose

Examine
effectiveness of
group psychoeducation for
medication
adherence in adults
suffering from
Schizophrenia

Sample

Methods

Study Results

This is an
analysis of
systematic
reviews and
randomized
controlled
trials focusing
on the
effectiveness
of group
psychoeducati
on for
Schizophrenic
patients.

Studies were
selected from
CINAHL, Pubmed, and
MEDLINE from
the years between
2009 and 2013

It was proven that
group
psychoeducation for
medication
adherence was
proven effective.
Rehospitalizations
were decreased, as
well as a reduction in
length of
hospitalization. It
also increased quality
of life, and selfesteem among other
things.

Level of
Evidence

Study
Limitations

Level 1:
Systematic
Review of
controlled
trials

Schizophrenia
can be very
challenging, there
is a high rate of
drop-out from
these programs,
and the education
cannot change
certain behaviors.
In addition, fear
of the treatment
plan resulted in
decreased
medication
adherence in
some cases.

Would
Use as
Evidenc
e to
Support
a
Change?
Yes, I
would
use to
support
the use
of
educatio
n and its
potential
effective
ness even
in
individua
ls with
schizoph
renia.
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Article Title,
Author

Study Purpose

87

Sample

Methods

Study Results

Level of
Evidence

Study
Limitations

Brewer, S.,
Whitten, S., &
Dziodzio, J.
(2016).
Implementation
of a COPD
clinical pathway
with a dedicated
respiratory
therapist team.
TEAM. Respira
tory
Care, 61(10),
OF53.

To evaluate the
effectiveness of a
clinical pathway to
reduce readmission
of COPD patients

A convenience
sample of 61
COPD patients
admitted to a
Maine hospital

A
multidisciplinary
task force created
an inpatient
COPD pathway
which included
standardized
medication orders.
Respiratory
Therapists were
trained to follow
the program
which included
discharge teaching
and patient
materials.

The Respiratory
Therapists found that
the primary medical
team was unwilling
to order specialty
service consults. The
therapists also found
that patients felt the
reason they were
readmitted is that
they felt they had
been discharged too
early on the previous
admission. More data
was required to
evaluate the
effectiveness of their
intervention.

Level 6:
Single
descriptive
or
qualitative
study.

The study results
speak more to the
disadvantages of
the protocol in
that they had
difficulty getting
providers to
order. Also, the
average length of
stay was slightly
longer at 4 days
as opposed to
3.76 in the control
group.

Duncan, P. W.,
Bushnell, C. D.,
Rosamond, W.
D., Berkeley, S.
J., Gesell, S. B.,
D'Agostino Jr,
R. B., & ...
Sissine, M. E.
(2017). The
Comprehensive
Post-Acute

To assess the
effectiveness of a
comprehensive,
evidence based,
post-acute care
model on patientcentered outcomes

40 units in
North Carolina
with a
recruitment
goal of 6000
patients (3000
per arm)
discharged
home with a
stroke or
transient

Randomized
control trial.
Two days after
discharge, patients
in the
experimental arm
received a phone
call and then a
two-week follow
up visit. The visit
included

The study is ongoing.
The primary outcome
is patient reported
functional status, but
secondary includes
medication
adherence and use of
community
resources.

Level 2:
Randomize
d Control
Trial

The study has not
completed as of
yet. It began in
2015 and is
ongoing which is
an indication that
the study is
accruing and
going as well as
possible. It
appears from

Would
Use as
Evidenc
e to
Support
a
Change?
This
study is a
lesson
learned
in
evaluatin
g culture
of the
organizat
ion
carefully
when
impleme
nting any
type of
interventi
on that
requires
multidisc
iplinary
cooperati
on.
Yes, this
study is
importan
t
evidence
that there
is merit
behind
an
instrume
nt
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Article Title,
Author

Study Purpose

Stroke Services
(COMPASS)
study: Design
and methods for
a clusterrandomized
pragmatic
trial. BMC
Neurology, 17,
(1-13).
doi:10.1186/s12
883-017-0907-1

Flink, M., &
Ekstedt, M.
(2016).
Prerequisites for
patient selfmanagement
learning at
hospital
discharge - an
observational
multiple case
study. Internatio
nal Journal of
Integrated
Care, 16(6), 1-

The study aim was"
to explore how the
hospital discharge
process provides a
learning
environment for
patients'
understanding of
their selfmanagement."
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Sample

Methods

ischemic
attack.
Patients are
adults 18 years
and older with
stroke or
transient
ischemic
attack who are
discharged
home from the
hospital.

assessment of
social and
functional
determinants of
health and an
individualized
COMPASS Care
Plan integrated
with a
communityspecific resource
data based.
Follow up phone
calls are made at
30 and 60 days
post discharge to
follow up on
interventions.
This was an
observational
case-study design.
Nurses were
provided with
information of
which much effort
was put into
developing, to
facilitate patient
understanding

Adult patients
being
discharged
from three
internal
medicine
"wards" and
caregivers/nurs
es in three
different
hospitals in
Sweden.

Study Results

Level of
Evidence

Study
Limitations

another search
that they may
have lowered
their total accrual
goal to 5000 from
the previous 6000
goal. (Found
here:
https://www.pcori
.org/researchresults/2015/com
paring-waysimprove-dailyfunctioningstroke-survivorsafter-they-leave)
Information given at
discharge was driven
by the needs of the
staff, as opposed to
the patient's level of
understanding.
Providing
information alone
does not promote
adherence to
medications. Patients
must be given the
time to learn in a
patient centered way,
however, due to time

Level 4:
case study
design

The findings of
this study were
not what had been
hoped by the
researchers who
had spent a great
amount of effort
developing an
instrument that
they hoped would
be used by nurses
to improve
discharge
teaching and

Would
Use as
Evidenc
e to
Support
a
Change?
develope
d to help
identify
communi
ty
resources
and a
structure
d plan to
help
patients
at high
risk for
readmissi
on.

The
importan
t
takeaway
here is
that there
must be
care with
developi
ng
teaching
materials
as a way
to
improve
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Article Title,
Author

Study Purpose

Sample

89

Methods

2.
doi:10.5334/ijic.
2768

Hanson, R. L.,
Habibi, M.,
Khamo, N.,
Abdou, S., &
Stubbings, J.
(2014).
Integrated
clinical and
specialty
pharmacy
practice model
for management
of patients with
multiple
sclerosis. Ameri
can Journal of
Health-System
Pharmacy, 71(6

Study Results

Level of
Evidence

limitations, patients
are not involved in
planning their care.

Integrated clinical
and specialty
pharmacy practice
model for
management of
patients with
multiple sclerosis

This is a
description of
a specialty
pharmacy
model utilizing
an
interdisciplinar
y approach
including
physicians,
nurses, and
pharmacists.

High rates of nonadherence to
expensive MS
drugs was
addressed by
creating a model
to incorporate a
dedicated team to
address barriers
including a
pharmacist, and
direct interaction
with the patient.

The model improves
patient compliance

Study
Limitations

medication
adherence.

Level 7:
Expert
Opinion

The model may
not be
reproducible
because it
involves an
investment of
time and
resources. Not all
clinics have
pharmacists
available to help
with medication
teaching.

Would
Use as
Evidenc
e to
Support
a
Change?
adherenc
e to
prescribe
d
regimens
.
Healthca
re
workers/
nurses
have
little time
to
educate
patients.
Yes, this
model
describes
somethin
g similar
to an
interdisci
plinary
team
model
that is
missing
from
some
units in
the
hospital.
These
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Article Title,
Author

90

Study Purpose

Sample

Methods

Study Results

To assess the impact
of baseline
schizophrenia
patient
characteristics on
adherence to
antipsychotic
medications

12,990
Patients with
schizophrenia
between the
ages of 25-64
on at least one
antipsychotic
medication

Descriptive
review of
Medicaid
healthcare claims
data between
2008 and 2011
from five states to identify

Patients who showed
adherence as a
baseline
characteristic and on
one particular
medication showed
continued adherence

Level of
Evidence

Study
Limitations

Level 6:
descriptive
study

This is a review
of information
found in a
database and is
completely
dependent on the
accuracy of the
database,

), 463-469.
doi:10.2146/ajh
p130495

Lafeuille, M.,
Frois, C.,
Cloutier, M.,
Duh, M. S.,
Lefebvre, P.,
Pesa, J., & ...
Durkin, M.
(2016). Factors
associated with
adherence to the
HEDIS quality
measure in
Medicaid
patients with
schizophrenia. A
merican Health
& Drug

Would
Use as
Evidenc
e to
Support
a
Change?
teams
can help
address
barriers
that
patients
may have
to
successfu
l
adherenc
e to
home
medicati
ons.
Yes, this
helps to
develop
the
assessme
nt
instrume
nt in that
if
patients
are
already
adherent
they are
likely to
continue
to be
adherent.
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Article Title,
Author

Benefits, 9(7),
399-409
Patel, S. D.,
Phuoc Anh
(Anne), N.,
Bachler, M., &
Atkinson, B.
(2017).
Implementation
of postdischarge
follow-up
telephone calls
at a
comprehensive
cancer
center. America
n Journal of
Health-System
Pharmacy, 74,
S42-S46.
doi:10.2146/ajh
p160805

Tomko, J. R.,
Ahmed, N.,
Mukherjee, K.,

91

Level of
Evidence

Study
Limitations

Study Purpose

Sample

Methods

Study Results

To reduce within 30
day readmissions by
developing and
implementing a
pharmacy-driven
postdischarge
follow-up telephone
call program to
assess adherence to
medications,
educate, and address
concerns

Convenience
sample of
pharmacists
employed by
MD Anderson
Cancer Center
and patients
discharged
during the
study period

Pharmacists were
trained in a
transition-of-care
telephone call
program. Patients
were called and
asked the
questions to
determine
adherence, answer
questions, and
address
discrepancies.

Patients who
received the phone
calls were less likely
to be rehospitalized
within 30 days
following discharge.
Out of 206 calls
completed, 87
patients were found
to have discrepancies
in their medication
regimen.

Level 4
Cohort
Study

Convenience
sample using a
pilot instrument
for the phone
interview.

To evaluate a
pharmacist-driven
discharge

Adult patients
discharged
from a

Retrospective
review of patient
charts

30 day hospital
readmission rates
were significantly

Level 6:
Single
descriptive

This may not be
replicable in a
facility that does

Would
Use as
Evidenc
e to
Support
a
Change?
Yes.
Although
it is not a
strong
study on
its own,
with
additiona
l similar
evidence
this
could
support
the
usefulnes
s of
pharmaci
st follow
up and/or
use of a
specific
instrume
nt when
calling
patients
after
discharge
.
Yes. This
study
showed
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Article Title,
Author

Study Purpose

Sample

Roma, R. S.,
Dilucente, D., &
Orchowski, K.
(2013).
Evaluation of a
discharge
medication
service on an
acute
psychiatric
unit. Hospital
Pharmacy, 48(4
), 314-320.
doi:10.1310/hpj
4804-314.test

medication service
for hospitalized
psychiatric patients.
Patients were
provided with
immediate access to
their medications
upon discharge.

behavioral
health unit to
home between
October 2010
and November
2011who were
prescribed
psychiatric
prescriptions
for selfadministration

Aikens, J. E.,
Trivedi, R.,
Aron, D. C., &
Piette, J. D.
(2015).
Integrating
support persons
into diabetes
telemonitoring
to improve selfmanagement
and medication
adherence. Jour
nal of General

To investigate the
potential benefits for
medication
adherence of
integrating a patient
-selected support
person into an
automated diabetes
telemonitoring and
self-management
program, and to
determine whether
these benefits vary

98 initially
non-adherent
adult patients
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Methods

Study Results

Level of
Evidence

decreased in studied
subjects compared to
total readmissions
the previous year

Quasiexperimental
design in which
patients chose
their preference
for telemonitoring
vs. interactive
voice response
calls.
This was a three
to six month
intervention in
which the patient
could choose a

Out of 98 patients,
42% opted to involve
a support person.
Those who opted for
the additional
support person
demonstrated
significantly greater
improvement in
long-term adherence
than those who
participated alone.
Distress was a
predictor that the

Study
Limitations

not provide
ambulatory
prescription
services.

Level 4:
Case
control
study

A weakness is
that patients
randomized
themselves.

Would
Use as
Evidenc
e to
Support
a
Change?
that
immediat
e
availabili
ty of
prescripti
ons upon
discharge
combine
d with
develop
ment of
support
decreases
readmissi
ons of
psychiatr
ic
patients.
Yes, this
study
brings
the idea
of
distress
as
predictor
s of
adherenc
e into the
picture,
but also
indicates
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Article Title,
Author

Study Purpose

Internal
Medicine, 30(3),
319-326.
doi:10.1007/s11
606-014-3101-9

by the patients
baseline of distress.

Balling, L.,
Erstad, B. L., &
Weibel, K.
(2015). Impact
of a transitionof-care
pharmacist
during hospital
discharge. Journ
al of The
American
Pharmacists
Association:
Japha, 55(4),
443-448.
doi:10.1331/JA

To assess the impact
of a transition-ofcare pharmacist
during hospital
discharge

Sample

1011 adult
patients were
educated and
452
interventions
by a
pharmacist
when
discharges
were
coordinated in
two inpatient
units in
Southern
Arizona
August 2012
to July 2013.

93

Methods

Study Results

support person to
receive updates
along with
guidance
regarding patient
assistance.
Distress was
measured at
baseline.

support person would
eventually become
less effective over
time, but not for
those who
participated alone.

This was a before
and after
comparison where
a pharmacist
provided
education and
medication
reconciliation as
well as
intervening to
prevent errors.

Readmission rate
dropped and several
interventions
included starting an
omitted medication,
preventing multiple
discharge problems
such as duplication
of therapy, improper
dose or quantity,
inappropriate
prescription,
preventing a drug
interaction etc.

Level of
Evidence

Study
Limitations

Level 3
Control
trial - no
randomizati
on

Convenience
sample. Not all
patients benefited
from the service.
there is no
account for
possible changes
in acuity, or
census.

Would
Use as
Evidenc
e to
Support
a
Change?
that
having a
support
person is
importan
t to help
with
adherenc
e when
combine
d with
additiona
l services
such as
telemonit
oring.
Yes. This
article
adds to
the
evidence
that
patients
have
barriers
to home
adherenc
e that
start in
the
hospital
setting
and that
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Article Title,
Author

94

Study Purpose

Sample

Methods

To collect patient
reported challenges
that they believe
contribute to illness
relapse

1084 adult
inpatients of
U.Penn and
Penn
Presbyterian
hospitals
between Nov.
2010 to July
2011.

Cross-Sectional
Survey

Investigate impact
of deviations from
prescribed regimen
in type 2 diabetes
patients can be
explained by
characteristics of the
individual
medication intake

104 nonadherent type2 diabetes
adult patients
from 37
community
pharmacies

Observational
study. Patients
were monitored
for 6 months to
see whether intake
occurred and
whether or not
intake occurred
within the agreed-

Study Results

Level of
Evidence

Study
Limitations

PhA.2015.1408
7

Kangovi, S.,
Grande, D.,
Meehan, P.,
Mitra, N.,
Shannon, R., &
Long, J. A.
(2012).
Perceptions of
readmitted
patients on the
transition from
hospital to
home. Journal
of Hospital
Medicine, 7(9),
709-712.
doi:10.1002/jhm
.1966
Vervloet, M.,
Spreeuwenberg,
P., Bouvy, M.
L., Heerdink, E.
R., de Bakker,
D. H., & van
Dijk, L. (2013).
Lazy Sunday
afternoons: The

Issues reported
included, feeling
unprepared for
discharge, difficulty
with ADLS, trouble
adhering or accessing
to discharge
medications, lack of
social support. low
socioeconomic status
(Medicaid or
uninsured) were
more likely to report
difficulty
understanding and
executing discharge
instructions, adhering
to medications, etc.
Medications in
evening and
weekends and
holidays are less
likely to be correctly
timed and also more
likely to be
completely missed.
The worst day was

Level 6
single
descriptive
study

Convenience
sample

Level 6
single
descriptive

Electronic
monitoring
devices do not
guarantee that it
is the patient
accessing the
medication nor
that the

Would
Use as
Evidenc
e to
Support
a
Change?
interventi
on can
help
improve
adherenc
e.
Yes, this
study
provides
additiona
l
confirma
tion that
there are
risk
factors
that may
be
included
in an
assessme
nt
instrume
nt.
Yes, this
provides
a good
basis for
consideri
ng
altering
timing of
medicati
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Article Title,
Author

negative impact
of interruptions
in patients' daily
routine on
adherence to
oral antidiabetic
medication. A
multilevel
analysis of
electronic
monitoring
data. European
Journal of
Clinical
Pharmacology,
69(8), 15991606.
Peeters, B., Van
Tongelen, I.,
Duran, Z.,
Yüksel, G.,
Mehuys, E.,
Willems, S., &
... Boussery, K.
(2015).
Understanding
medication
adherence
among patients
of Turkish
descent with
type 2 diabetes:
a qualitative

Study Purpose

Sample

moments and the
patient

To explore
perspectives of
Turkish migrants
with type 2 diabetes
on adherence to oral
hypoglycemic
agents

21 adult
Turkish
descent
patients
recruited from
primary care
and
community
sources.
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Methods

Study Results

upon time period
(correct time)

Sunday at 33%
compliance.

In-depth
interviews.
Analysis was
guided by a
grounded theory
approach.

Healthcare providers
should explore
patient perspectives
of medication
adherence with their
patients due to
several different
beliefs about
medications, as well
as problems with
forgetfulness,
feelings of
depression, and lack
of social support.

Level of
Evidence

Study
Limitations

medication was
actually taken.

Level 6
qualitative
study

Small sample

Would
Use as
Evidenc
e to
Support
a
Change?
on
schedule
for nonadherent
patients.

Yes,
combine
d with
other
evidence
this
article
reminds
of some
of the
many
other
aspects
that can
factor
into non-
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Article Title,
Author
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Study Purpose

Sample

Methods

Study Results

A national survey
conducted to
determine selfreported adherence
while also assessing
demographic,
attitudinal and
behavioral factors
related to
prescription drug
compliance.

1020
American
adults aged 40
and older
(median age of
60) prescribed
ongoing
medication
(average of
four prescribed
medications)
for a chronic
condition (the
group that uses
prescription
medication
most regularly
and therefore
at greatest risk
for
nonadherence)
.

Independent
random-sample
telephone survey
conducted by a
research firm.
Survey assessed
nine nonadherant
behaviors:, in the
past 12 months,
patients failed to
fill or refill a
prescription,
missed a dose,
took a lower or
higher dose than
prescribed,
stopped a
prescription early,
took an old
medication for a
new problem,
took someone
else’s medicine or
forgot whether
they’d taken a
medication.

48% earned a grade
of A or B 36 percent
a grade of C or D. 15
percent Predictors
Regression
modeling, identified
the six key predictors
of adherence. Those
include – in order of
magnitude:
Patients’ personal
connection with a
pharmacist or
pharmacy staff;
How easy it is for
them to afford their
medications;
The level of
continuity they have
in their health care;
How important
patients feel it is to
take their medication
exactly as prescribed;

Level of
Evidence

Study
Limitations

Level 6
descriptive
study random
survey

A telephone
survey is
dependent on the
honesty of the
respondent.
Respondents may
be reluctant to
admit undesirable
behaviors.
There are
questions about
connectedness for
both doctors and
pharmacists. The
study emphasizes
the connectedness
with a pharmacist
as a behavior
related to
adherence. The
study was
conducted for the
National
Community
Pharmacy
Association so

study. Ethnicity
& Health, 20(1),
87-105.
doi:10.1080/135
57858.2014.890
174
National
Community
Pharmacist's
Association.
(2013).
Medication
Adherence in
America: A
national report
card. Retrieved
from
http://www.ncp
a.co/adherence/
AdherenceRepo
rtCard_Full.pdf

Would
Use as
Evidenc
e to
Support
a
Change?
adherenc
e.

Yes, this
research
contains
useful
informati
on to
learn
about
reasons
for nonadherenc
e and
methods
that may
help
promote
adherenc
e.
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Article Title,
Author

Cawthon, C.,
Mion, L.,
Willens, D.,
Roumie, C., &
Kripalani, S.
(2014).
Implementing
routine health
literacy
assessment in
hospital and
primary care
patients. The
Joint
Commission
Journal on
Quality and
Patient Safety:
Joint
Commission
Resources,
40(2): 68-76.

Study Purpose

Addressing health
literacy is a national
health priority. The
purpose of this study
was to measure the
acceptability,
adoption,
appropriateness,
feasibility, fidelity,
and sustainability of
a three-item
measure called the
Brief Health
Literacy Screen
(BHLS)

Sample

Data was
collected
between
November
2010 and April
2012 on
55,611 adults
primarily
middle-aged
and Caucasian.

97

Methods

Approximately
5000 inpatient and
outpatient nursing
staff were
informed and
educated about
the instrument.
The instrument
was embedded
into the electronic
health record and
asked at
admission to the
inpatient or
outpatient setting:
Questions
included: " The
BHLS consists of
three questions
asking about
confidence filling
out forms, if they
ask others to help
them read hospital
materials, and
difficulty learning

Study Results

How well informed
they feel about their
health; and
The extent to which
their medication
causes unpleasant
side effects.
The study found that
it was feasible and
efficient to include
the three-question
assessment as part of
the nursing
assessment process.
There are
instruments that are
lengthier to
administer, but not
feasible. This study

Level of
Evidence

Study
Limitations

may be somewhat
biased in the
questionnaire as
this has not been
found in other
studies.
Level three
controlled
trial

This study was to
test feasibility of
implementing a
three question
assessment.
Further study is
needed to
evaluate
effectiveness of
the instrument.
Further
development of
appropriate
patient resources
as well as training
for nurses to
administer the test
were identified.

Would
Use as
Evidenc
e to
Support
a
Change?

Yes, the
Joint
Commiss
ion is an
accrediti
ng body
of our
hospital
system
and the
statement
s made
as well
as the
reference
s to the
importan
ce of
assessing
patients'
specific
learning
needs
holds
additiona
l weight.
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Article Title,
Author

Study Purpose

Sample

98

Methods

Level of
Evidence

Study
Limitations

The review states
that as much as 20%
of breast cancer
patients are
depressed. Depressed
patients tend to be
less adherent to their
therapy. Mortality
may be increased due
to nonadherence to
oral therapy. Women
who are depressed
had greater financial
burden, lower quality
of life, and shorter
time to recurrence of
their cancer.

Level 1
systematic
Review and
metaanalysis

Limitations
mentioned in the
study included.
all studies
included
participants with
depression but
only one study
included this as a
variable and none
of the studies
focused
exclusively on the
effect of
depression on
adherence.

Yes,
study
supports
importan
ce of
treating
depressio
n to
improve
adherenc
e

The study found that
older age, and
younger age (not
middle age) along
with therapy related

Systematic
review of
literature.
Level one
evidence

Patient
characteristics
differed widely so
difficult to
generalize.

Yes
Supports
importan
ce of
controlli

Study Results

about medical
condition due to
difficulty
understanding
written materials.
Mausbach, B.
T., Schwab, R.
B., & Irwin, S.
A. (2015).
Depression as a
predictor of
adherence to
adjuvant
endocrine
therapy (AET)
in women with
breast cancer: a
systematic
review and
meta-analysis.
Breast Cancer
Research and
Treatment,
152(2), 239246.
doi:10.1007/s10
549-015-3471-7
Verbrugghe, M.,
Verhaeghe, S.,
Lauwaert, K.,
Beeckman, D.,
& Van Hecke,

To analyze the
available evidence
concerning the
effects of depression
on non-adherence to
adjuvant endocrine
therapy.

Breast cancer
patients taking
endocrine
therapy with a
total
population of
17,735 patients
with breast
cancer. The
articles were
published
between 2004
to 2014. .

To gain insight into
the determinants and
associated factors of
nonadherence in

25 studies
focusing on
adherence to
oral anti-

Systematic review
and meta-analysis
Level of
Evidence: Level 1
systematic
Review and metaanalysis
Limitations: 1.
Only 9 studies
included, 2. all
studies included
participants with
depression but
only one study
included this as a
variable, 3. None
of the studies
focused
exclusively on the
effect of
depression on
adherence.
Systematic review
of literature

Would
Use as
Evidenc
e to
Support
a
Change?

ADDRESSING BARRIERS TO ADHERENCE

Article Title,
Author

Study Purpose

Sample

A. (2013).
Determinants
and associated
factors
influencing
medication
adherence and
persistence to
oral anticancer
drugs: A
systematic
review. Cancer
Treatment
Reviews, 39(6),
610-621.
doi:10.1016/j.ctr
v.2012.12.014

patients taking
cancer therapy

cancer therapy
drugs

Bender, C. M.,
Gentry, A. L.,
Brufsky, A. M.,
Casillo, F. E.,

To assess patient
illness or treatment
factors that may
predict

91 women
with early
stage breast
cancer

99

Methods

Study Results

Level of
Evidence

side effects were the
predominant factors
in non-adherence.
Better attention to
management of side
effects may help
patients adhere to
their oral
chemotherapy and
continue to take it
longer.

Repeated measure
design to assess
adherence
continuously for

Found lower
adherence for women
with depression,
anxiety, or symptoms

Study
Limitations

Approaches may
need to be
taylored to each
person to be
effective (given a
choice)
Only two studies
used MEMS to
detect when
medication vials
were accessed.
Patients need to
be "wellinformed"

Level 6
repeated
measure
design

Sample size may
have been a factor
related to
cognitive

Would
Use as
Evidenc
e to
Support
a
Change?
ng side
effects to
promote
adherenc
e
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Article Title,
Author

Cohen, S. M.,
Dailey, M. M., .
. . Sereika, S.
M. (2014).
Influence of
patient and
treatment
factors on
adherence to
adjuvant
endocrine
therapy in breast
cancer.
Oncology
Nursing Forum,
41(3), 274.
doi:10.1188/14.
ONF.274-285
Greer, J. A.,
Amoyal, N.,
Nisotel, L.,
Fishbein, J. N.,
Macdonald, J.,
Stagl, J., . . .
Pirl, W. F.
(2016). A
systematic
review of
adherence to
oral
antineoplastic
therapies.
Oncologist,

Study Purpose

Sample

100

Methods

Study Results

nonadherence to
endocrine therapy

receiving
endocrine
therapy

the first 18
months of
endocrine therapy.
Assessments
completed at four
time points to
measure
adherence rates
between
beginning and 18
months.

of illness prior to
starting therapy.
Adherence to
endocrine therapy
was lower in first
eight months for
those with negative
mood. Women with
breasts cancer may
be at risk for
nonadherence if they
experience
depression or anxiety
and symptoms prior
to initiating therapy.

To determine causes
of nonadherence and
factors that may
help promote
adherence.

63 studies of
adults with
cancer who are
prescribed oral
chemotherapy
drugs. Studies
published
between
Jaunary 1,
2003 to June
30, 2015.

Systematic
literature review

Adherence to
endocrine therapy
decreased over time
to about 50%
adherence by the 5th
year.
Depression played a
significant role in
adherence, especially
in younger adults.
Asking patients
about adherence in
the affirmative such
as "What percentage
of the time did you

Level of
Evidence

Study
Limitations

function. More
research is needed
to clarify
cognitive function
in adherence.

Level 1:
Systematic
Review

The researchers
found very
significant
limitations in
most of the
studies they
reviewed, mostly
concerning bias.
In fact all but
three studies were
felt to be very
biased. Authors
felt more study is
needed to
determine

Would
Use as
Evidenc
e to
Support
a
Change?

Yes, I
will use
this for
the
informati
on
regarding
the effect
of
depressio
n on
adherenc
e partly
because
the same
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Article Title,
Author

21(3), 354-376.
doi:10.1634/the
oncologist.2015
-0405

Study Purpose

Sample

101

Methods

Study Results

take your
medications" or
"How well did you
take your
medications last
month" as opposed to
"How many pills did
you miss" may yield
more reliable and
accurate responses.
Overall, adherence
declines over time
with varying reasons.

Level of
Evidence

Study
Limitations

effective
promotion of
adherence.

Would
Use as
Evidenc
e to
Support
a
Change?
is
substanti
ated by
other
studies as
well,
however,
the
questions
asked in
the
individua
l studies
to help
determin
e
individua
l
adherenc
e factors
and
adherenc
e were
felt to be
biased by
the
researche
rs doing
the
literature
review.
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Article Title,
Author

Study Purpose

Sample

102

Methods

Study Results

One in five adults
reported taking at
least four
prescription drugs
with 55% taking at
least one.
35% of patients
taking four or more
prescription pills
reported taking lower
dosage, or skipped
doses (and if
uninsured did not fill
the prescription)
compared to 25% of
those taking three or
fewer. Income of
$40,000 a year or
less was another
predictive factor of
lowering, skipping,
or not filling a
prescription.
OAS CAHPS survey
showed positive
results; however, the
sample of surveys
returned was
insufficient to show
statistical
significance. The
Likert survey did
show that patients

Kaiser Family
Foundation.
(2017). Public
opinion on
prescription
drugs and their
prices. [online
slide
presentation of a
2015-2017
tracking poll].
Retrieved from
https://www.kff.
org/slideshow/p
ublic-opinionon-prescriptiondrugs-and-theirprices/

A public opinion
poll on prescription
drugs and their
prices

1171 adults
age 18 and
older

Telephone survey
- Adults were
surveyed by
telephone between
April 17-23, 2017
weighted to
balance the
sample
demographics to
match estimates
of the national
population
according to the
2015 census
bureau (KFF.org,
2017)

Parr, K. (2017).
Health literacy:
Improving
understanding
of discharge
instructions.
Unpublished
manuscript,
School of
Nursing, Liberty

To improve patient
satisfaction and
understanding of
discharge
instructions by
factoring in literacy
into discharge
instructions and
using teach-back to

Adults aged 18
- 89 having
outpatient
surgery
without
cognitive
impairments.

Instructions were
provided to
patient at a 5th to
6th grade reading
level with pictures
if needed. Patients
were asked to
teach-back what
they learned. Data
was collected one

Level of
Evidence

Study
Limitations

Level 6
survey

Convenience
sample that may
include sampling
error and bias
based on adults
willing to answer
questions over the
phone could
misrepresent the
population as a
whole.

Level 6
single
descriptive
pilot study

Returned surveys
did not show a
statistical
difference in
CAHPs survey
partly due to
limited time
frame of study
and limited

Would
Use as
Evidenc
e to
Support
a
Change?
Yes, this
is a
useful
survey to
help
determin
e
warning
signs and
barriers

Yes, this
speaks
well to
how
literacy
impacts
patient
educatio
n, as well
as
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Article Title,
Author

Study Purpose

Sample

University,
Lynchburg, Va.

assess
understanding.

Boucher, J.,
Lucca, J.,
Hooper, C.,
Pedulla, L., &
Berry, D. L.
(2015). A
structured
nursing
intervention to
address oral
chemotherapy
adherence in
patients with
non-small cell
lung cancer.
Oncology
Nursing Forum,
42(4), 383.

To evaluate a nurseled intervention to
enhance mediation
knowledge and
adherence using the
Multinational
Association for
Supportive Care in
Cancer Oral Agent
Teaching Instrument
(MOATT)

30 adult
patients with
lung cancer

Spoelstra, S. L.,
& Sansoucie, H.
(2015). Putting

To develop a
synthesis of the
literature

Extensive
review of
literature on

103

Methods

month for patients
discharged and
compared to
previous
satisfaction
scores. A Likert
scaled phone
survey was also
used to collect
information.
Longitudinal
descriptive
feasibility study to
assess a structured
nurse-led
education session
using MOATT. A
72 hour phone
follow up was
provided after
initiatial education
of the participant.
Participants
completed a
knowledge rating
scale, adherence
scale at the end of
the first cycle of
oral
chemotherapy.
Comprehensive
review of
literature

Study Results

Level of
Evidence

felt better prepared
and better educated
for discharge home
after surgery.

Study
Limitations

sample of
returned surveys.

Would
Use as
Evidenc
e to
Support
a
Change?
supportin
g the
teachback
method
of patient
educatio
n

The structured
MOATT program
were feasible for the
program, and the
adherence and
knowledge outcomes
were encouraging.
Additional studies
are needed to
measure objective
adherence measures
and strategies for
delivering supportive
care to patients in
their homes.

Level 6
longitudinal
descriptive
feasibility
study

The findings were
applicable to a
single drug,
erlotinib. Due to
the single arm
study the article
states that proof
of improvement is
not possible for
this study despite
encouraging
results.

It adds to
the
knowled
ge
however
it is a
small
study.

The literature
supports using
patient feedback and

Level 1
systematic
review of

Information about
technology
becomes outdated

Yes, this
is a
helpful
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Article Title,
Author
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Study Purpose

Sample

Methods

Study Results

evidence into
practice:
Evidence-based
interventions for
oral agents for
cancer. Clinical
Journal of
Oncology
Nursing, 19(3),
60-72.
doi:10.1188/15.
S1.CJON.60-72

surrounding the
issue of adherence
and identify
effective
interventions for the
promotion,
treatment, and
management of
adherence to oral
agents for cancer.

the topic of
medication
adherence.
Adult Patients
with cancer as
well as other
populations
were included.
The review
was conducted
in 2014 and
included data
within a tenyear timeframe.

including a
"weight of
evidence
classification
schema to assess
levels of evidence
of each source.
Limitation:
technology has
changed since
review

Irwin, M., &
Johnson, L. A.
(2015). Factors
influencing oral
adherence:
Qualitative
metasummary
and
triangulation
with
quantitative
evidence. Clinic
al Journal of
Oncology
Nursing, 19(3),

A review to
synthesize evidence
regarding factors
that impact
medication
adherence and to
identify implications
for practice.

159 research
studies from
PubMed and
CINAHL:
83
Quantitative;
46 qualitative;
17 mixedmethods; 9
systematic
reviews; 3
meta-analysis;
and 1
integrated
review. Study

Qualitative
metasummary and
triangulation with
quantitative
evidence.
Evidence includes
Systematic
Reviews and
Meta-analysis,
quantitative
studies, and
mixed methods
studies.

multicomponent
interventions.
Literature also
suggests that text
messaging,
automated voice
response and
treatment of
depression are likely
to be effective
methods of
promoting adherence
to oral medications.
Factors effecting
adherence included
decreased dosing to
once a dya to
improve adherence.
Forty-four factors
were identified to
have an influence on
adherence.

Level of
Evidence

Study
Limitations

research
combined
with level 5
review of
literature

quickly and there
is a warning that
this could be the
case for any
technology
recommended in
this article.

Level 1
metaanalysis
with
triangulatio
n

Qualitative
studies may
contain varied
classification of
themes and
concepts. This
was adjusted by
secondary review
to establish
reliability.

Would
Use as
Evidenc
e to
Support
a
Change?
review
with
combine
d
evidence
to
support
various
strategies
to help
with
adherenc
e.

Yes, this
is very
helpful
for
establishi
ng a very
reliable
list of
warning
signs to
barriers
with
multiple
research
studies
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Article Title,
Author

Study Purpose

6-30.
http://dx.doi.org
.ezproxy.liberty.
edu/10.1188/15.
S1.CJON.6-30

Wooldridge, K.,
Schnipper, J. L.,
Goggins, K.,
Dittus, R. S.,
&Kripalani, S.
(2016).
Refractory
primary
medication
nonadherence:
Prevalence and
predictors after
pharmacist
counseling at
hospital
discharge. J.
Hosp. Med., 11,
48–51.
doi:10.1002/jhm
.2446

To evaluate the
prevalence and
predictors of
refractory primary
nonadherence in
patients hospitalized
with acute
cardiovascular
conditions who
received counseling
from a pharmacist
before discharge.

Sample

samples
ranged from
10 to 101,028.
Large studies
utilized
insurance and
pharmacy
databases for
descriptive
analysis.
341 patients
who received
discharge
counseling
during a
previous
pharmacist
study and had
new
medications to
be filled. Mean
age was 61.3
years.

105

Methods

Study Results

Data was obtained
from medical
record review and
follow up phone
calls.

The primary outcome
was percentage of
patients who reported
not filling at least
one discharge
prescription. Patients
were asked to
provide a reason the
medication was not
filled.
Single marital status,
lower income, and
having more than 10
medications were
significantly
associated with not
filling medications.
Reasons included
cost by 23.5% of
patients. Additional
reasons include lack
of time to go to the
pharmacy,

Level of
Evidence

Study
Limitations

Level 6
single
descriptive
study

No limitations
were mentioned
however, the
study may be
difficult to
replicate for many
institutions do not
have pharmacy
staff to support.

Would
Use as
Evidenc
e to
Support
a
Change?
supportin
g the
prevalen
ce and
impact of
each
barrier.

Yes, it
adds to
the
knowled
ge of
warning
signs and
barriers
to
adherenc
e.
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Article Title,
Author

Barthélémy, P.,
Asmane-De la
Porte, I., Meyer,
N., Duclos, B.,
Serra, S.,
Dourthe, L.-M.,
. Kurtz, J.-E.
(2014).
Adherence and
patients'
attitudes to oral
anticancer
drugs: A
prospective
series of 201
patients
focusing on
targeted
therapies.
Oncology,
88(1), 1.
doi:10.1159/000
366226

Study Purpose

To see if patients
who receive an
education regarding
importance of
adherence to five
full years of
hormonal therapy
felt better informed
and adhered to their
therapy longer

Sample

201 women
with various
stages of
breast cancer
in Alsace,
France
between 2012
and 2013.

106

Methods

Study Results

A 15-item survey
was given to
patients located
on four oncology
units.

medication not
delivered or
dispensed, and
inability to afford the
medications.
The researchers
concluded that better
education, and
education repeated at
intervals throughout
therapy could be
beneficial to
increasing adherence
to oral therapies of
all types.

Level of
Evidence

Study
Limitations

Level 6
single
descriptive
study

The researchers
did not ask if the
patients had
educated
themselves in any
way.

Would
Use as
Evidenc
e to
Support
a
Change?

Yes, this
supports
the vast
literature
on the
importan
ce of
educatio
n in the
presence
of some
literature
that
implies a
limit on
its
effective
ness. It
may be
more
about the
method
and
timing,
than
simply
checking
it off a
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Article Title,
Author
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Study Purpose

Sample

Methods

Moss, R. C.,
Lowe, G. C.,
Frampton, C.
A., & Revell, P.
(2014). A nurseled randomised
controlled trial
of a structured
educational
programme for
patients starting
warfarin
therapy. Journal
of Research in
Nursing, 19(5),
402-412.
doi:10.1177/174
4987113515261

To see if a
structured
educational program
at implementation of
an oral medication
improves
knowledge,
satisfaction and
therapeutic benefits
of the drug

A randomized
controlled trial
of 45
hospitalized
patients being
discharged on
warfarin

divided into two
groups, one
receiving the
“usual” care, and
the other provided
with structured
counseling and an
educational video.
Both groups were
administered
questionnaires at
discharge and
again at 3 months.
Both groups were
also assessed for
satisfaction and
time in
therapeutic INR.

Murphy, C. C.,
Bartholomew,
L. K.,
Carpentier, M.
Y., Bluethmann,
S. M., &
Vernon, S. W.
(2012).
Adherence to
adjuvant
hormonal

To assess for
barriers to
adherence

This is a
review of
twenty-nine
peer-reviewed,
primary
studies of
female breast
cancer
survivors
taking
endocrine

Nonadherence
rates were as high
as 71% at five
years. Factors that
were attributed to
improved
adherence
included taking
more medications
at baseline,
referral to an

Level of
Evidence

Study
Limitations

Patients who
received the
intervention had
significantly better
knowledge of their
therapy than the
control group. In
addition, they also
reported improved
satisfaction and
better time in the
target INR range.

Level 2
randomized
controlled
trial

A relatively small
number of
patients in one
location limits
generalization

The study concludes
that many of these
factors are not
modifiable and that
further research is
needed to identify
potentially
modifiable factors so
that interventions can
be developed to
improve adherence

Level 1
systematic
review of
primary
research
studies

Data was
collected up to
2012 which limits
to certain types of
therapies taken.
New therapies
have been
developed which
may have
impacted the rates
of nonadherence

Study Results

Would
Use as
Evidenc
e to
Support
a
Change?
list as a
one-time
task.
Yes, it
adds to
the
multitude
of
literature
confirmi
ng that
educatio
n
provided
in initial
and
concurre
nt time
periods is
beneficia
l
Yes, this
is a good
study
helping
to
identify
some of
the most
common
barriers
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Article Title,
Author

Study Purpose

therapy among
breast cancer
survivors in
clinical practice:
a systematic
review. Breast
Cancer
Research and
Treatment,
134(2), 459478.
doi:10.1007/s10
549-012-2114-5
Roop, J. C., &
Wu, H.-S.
(2014). Current
practice patterns
for oral
chemotherapy:
results of a
national survey.
Oncology
Nursing Forum,
41(2), 185A110.
doi:10.1188/14.
ONF.41-02AP

The three-phase
study purpose was
to develop, validate
and implement a
national online
survey regarding
current practice
patterns in nursing
when caring for
patients prescribed
oral chemotherapy
treatments. The
survey was
developed to
explore and describe
current nursing
practices especially
regarding challenges
related to caring for

108

Sample

Methods

Study Results

therapy
published
between 1998
and 2012.

oncologist and
earlier year of
diagnoses. The
factors attributed
to worse
adherence
included older
age, increased
out-of-pocket
costs, switching
therapies and side
effects.

and decrease
mortality related to
non-adherence.

The survey
was sent to
5000 nurses
who were
members of
the oncology
nursing
society. 577
nurses
responded.
51% of the
nurses worked
in practices
that had
developed
specific
policies and
procedures and
resources for

This is a survey
study. The survey
contained 17
force-choiced
items and one
free-text item.

The most frequently
identified barriers to
adherence were cost
and adverse effects
of the medication.
The free-text column
responses have an
interesting common
theme regarding
erratic procedures
and inadequate
interdisciplinary
communication.

Level of
Evidence

Study
Limitations

in women on
endocrine
therapy.

Level 6
survey
study

This study has the
limitations of an
online survey in
which a
convenience
sample is
included which
may represent a
select group of
nurses who have
time and are
willing to
complete a
survey.

Would
Use as
Evidenc
e to
Support
a
Change?

Yes, this
survey
free text
informati
on
confirms
inadequa
te
interdisci
plinary
communi
cation is
identified
as a
factor
that may
contribut
e to
lower
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Article Title,
Author

Study Purpose

Sample

patients taking oral
chemotherapy, and
to identify common
barriers to treatment
adherence in
patients.

patients taking
oral therapy.

109

Methods

Study Results

Level of
Evidence

Study
Limitations

Would
Use as
Evidenc
e to
Support
a
Change?
adherenc
e of
medicati
on in
patients.
It also
supports
cost and
adverse
effects as
two
common
barriers
to
adherenc
e.
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APPENDIX B: Permission to use The Iowa Model Revised and Implementation Strategies
for Evidence-Based Practice
Permission to Use the Iowa Model Revised: Evidence-Based Practice to Promote
Excellence in Health Care
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-survey.com>
Sun 12/10/2017 9:40 PM

To:

Washburn, Donna (Nursing) <djwashburn@liberty.edu>;

You have permission, as requested today, to review and/or reproduce The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health
Care. Click the link below to open.

The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the
internet.

Citation: Iowa Model Collaborative. (2017). Iowa model of evidence-based practice: Revisions and validation. Worldviews on Evidence-Based Nursing, 14(3), 175-182.
doi:10.1111/wvn.12223

In written material, please add the following statement:

Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015. For permission to use or reproduce, please contact the University of Iowa
Hospitals and Clinics at 319-384-9098.

Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions.

Permission to use Implementation Strategies for EBP
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-survey.com>
Reply|
Sun 12/10/2017, 9:40 PM
Washburn, Donna (Nursing)
You have permission, as requested today, to review and/or use the Implementation Strategies for EBP (Evidence-Based Practice Implementation
Guide ). Click the link below to open.
©

Implementation Strategies for Evidence-Based Practice
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the internet.
Citation: Cullen, L., & Adams, S. L. (2012). Planning for implementation of evidence-based practice. Journal of Nursing Administration, 42(4),
222-230. doi:10.1097/NNA.0b013e31824ccd0a
In written material, please include the following statement:
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2012. For permission to use or reproduce,
please contact the University of Iowa Hospitals and Clinics at 319-384-9098.
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions.
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APPENDIX C: CITI Training Completion Certificate
COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM)
COMPLETION REPORT COURSEWORK TRANSCRIPT
COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM)
COMPLETION REPORT - PART 1 OF 2 COURSEWORK REQUIREMENTS*

NOTE: Scores on this Requirements Report reflect quiz completions at the time all requirements
for the course were met. See list below for details. See separate Transcript Report for more recent
quiz scores, including those on optional (supplemental) course elements.

Name: Donna Washburn (ID: 1645501)
Email: Djwashburn@liberty.edu
Institution Affiliation:
Institution Unit:

Liberty University (ID: 2446)

Nursing

Curriculum Group: Biomedical Research - Basic/Refresher
Course Learner Group: Biomedical & Health Science Researchers
Stage: Stage 1 - Basic Course
Description: Choose this group to satisfy CITI training requirements for Investigators and staff
involved primarily in biomedical research with human subjects.
Report ID:

20817799

Completion Date:

10-Sep-2016

Expiration Date:

10-Sep-2019

Minimum Passing:

80

Reported Score*:

98

REQUIRED AND ELECTIVE MODULES ONLY

SCORE
DATE
COMPLETED
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Belmont Report and CITI Course Introduction (ID: 1127)

112
04-Mar-2010

3/3
(100%)

History and Ethics of Human Subjects Research (ID: 498)

17-Mar-2010

7/7
(100%)

Basic Institutional Review Board (IRB) Regulations and Review Process (ID: 2)

17-Mar-2010

4/5 (80%)

Informed Consent (ID: 3)

17-Mar-2010

4/4
(100%)

Social and Behavioral Research (SBR) for Biomedical Researchers (ID: 4)

18-Mar-2010

4/4
(100%)

Records-Based Research (ID: 5)

18-Mar-2010

2/2
(100%)

Genetic Research in Human Populations (ID: 6)

18-Mar-2010

2/2
(100%)

Populations in Research Requiring Additional Considerations and/or Protections (ID: 16680)

10-Sep-2016

5/5
(100%)

FDA-Regulated Research (ID: 12)

18-Mar-2010

5/5
(100%)

Research and HIPAA Privacy Protections (ID: 14)

28-Sep-2015

5/5
(100%)

Vulnerable Subjects - Research Involving Workers/Employees (ID: 483)

28-Sep-2015

4/4
(100%)

Recognizing and Reporting Unanticipated Problems Involving Risks to Subjects or Others in Biomedical
Research

10-Sep-2016

(ID: 14777)
Conflicts of Interest in Research Involving Human Subjects (ID: 488)

5/5
(100%)

18-Mar-2010

2/2
(100%)

Liberty University (ID: 15111)

10-Sep-2016

No Quiz

For this Report to be valid, the learner identified above must have had a valid affiliation with the CITI Program subscribing institution
identified above or have been a paid Independent Learner.

Verify at: https://www.citiprogram.org/verify/?694a5a80-3014-4f34-8e0a-31434f88ec20

CITI Program
Email: support@citiprogram.org Phone: 888-529-5929
Web: https://www.citiprogram.org
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COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM)
COMPLETION REPORT - PART 2 OF 2 COURSEWORK TRANSCRIPT**

** NOTE: Scores on this Transcript Report reflect the most current quiz completions, including
quizzes on optional (supplemental) elements of the course. See list below for details. See
separate Requirements Report for the reported scores at the time all requirements for the course
were met.

Name:

Donna Washburn (ID: 1645501)

Email:

Djwashburn@liberty.edu

Institution Affiliation: Liberty University (ID: 2446)
Institution Unit:

Nursing

Curriculum Group: Biomedical Research - Basic/Refresher
Course Learner Group: Biomedical & Health Science Researchers
Stage:

Stage 1 - Basic Course

Description:
Choose this group to satisfy CITI training requirements for Investigators and staff involved primarily in biomedical research
with human subjects.

Report ID:

20817799

Report Date:

13-Sep-2016

Current Score**:

100

REQUIRED, ELECTIVE, AND SUPPLEMENTAL MODULES

MOST
RECENT

SCORE

History and Ethics of Human Subjects Research (ID: 498)

13-Sep-2016

7/7 (100%)

Students in Research (ID: 1321)

13-Sep-2016

5/5 (100%)

Liberty University (ID: 15111)

10-Sep-2016

No Quiz

Informed Consent (ID: 3)

13-Sep-2016

5/5 (100%)

Social and Behavioral Research (SBR) for Biomedical Researchers (ID: 4)

13-Sep-2016

4/4 (100%)

Belmont Report and CITI Course Introduction (ID: 1127)

13-Sep-2016

3/3 (100%)

Records-Based Research (ID: 5)

13-Sep-2016

3/3 (100%)

Genetic Research in Human Populations (ID: 6)

13-Sep-2016

5/5 (100%)

Vulnerable Subjects - Research Involving Prisoners (ID: 8)

13-Sep-2016

4/4 (100%)
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Vulnerable Subjects - Research Involving Children (ID: 9)

13-Sep-2016

3/3 (100%)

Vulnerable Subjects - Research Involving Pregnant Women, Human Fetuses, and Neonates (ID: 10)

13-Sep-2016

3/3 (100%)

FDA-Regulated Research (ID: 12)

13-Sep-2016

5/5 (100%)

Research and HIPAA Privacy Protections (ID: 14)

28-Sep-2015

5/5 (100%)

Vulnerable Subjects - Research Involving Workers/Employees (ID: 483)

28-Sep-2015

4/4 (100%)

Hot Topics (ID: 487)

13-Sep-2016

No Quiz

Conflicts of Interest in Research Involving Human Subjects (ID: 488)

13-Sep-2016

5/5 (100%)

Basic Institutional Review Board (IRB) Regulations and Review Process (ID: 2)

13-Sep-2016

5/5 (100%)

Recognizing and Reporting Unanticipated Problems Involving Risks to Subjects or Others in Biomedical Research
(ID: 14777)

10-Sep-2016

5/5 (100%)

Populations in Research Requiring Additional Considerations and/or Protections (ID: 16680)

10-Sep-2016

5/5 (100%)

For this Report to be valid, the learner identified above must have had a valid affiliation with the CITI Program subscribing institution
identified above or have been a paid Independent Learner.

Verify at: https://www.citiprogram.org/verify/?694a5a80-3014-4f34-8e0a-31434f88ec20

Collaborative Institutional Training Initiative (CITI Program)
Email: support@citiprogram.org Phone: 888-529-5929
Web: https://www.citiprogram.org
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APPENDIX D: Medication Adherence Barrier Identification Instrument
(Version used for data collection)
Medication Adherence Barrier Identification Instrument
Instructions for use in practice: Place a check next to each warning sign, then mark associated
potential barrier identified (Refer to an oncology navigator for further evaluation and
coordination of interdisciplinary care)
For Data Collection: Gender:_____Year of Birth:______ Unique ID:______________ OSS
Following: y/n
Barrier:

Warning Signs:

Financial/Social
Support

o
o
o
o
o

Depression/Distress/
Anxiety

o
o
o

Medical Related
Concerns

o
o
o

Related cues: Side
effects/Effectiveness/Medicatio
n Reconciliation
Issues/relationship with
provider/multiple
comorbidities/ Polypharmacy/
Poor Performance Score
(ECOG)/cancer therapy last 6
months
Behavior/Lifestyle
Related cues:
Forgetting/Don't think it's
needed/Didn't "agree" to take
it/Don't like taking it/ too
busy/Away from home/no
established routine

Educational

o
o
o
o
o
o
o
o
o
o
o
o
o
o
o

Age 65 or higher and one or more of the
following:
Unmarried and/or absence of social support
Medicaid eligible
Income less than 50,000 dollars/year
Limited pharmacy access (location of residence
related to pharmacy, resides outside of city, lack
of transportation)
PHQ-9 Depression screen Score of = / > 15
NCCN Distress Score of = / > 4
Diagnoses of anxiety, or on medication for
anxiety
More than 10 medications
Uncontrolled illness
Unexpected side effects and/or lack of expected
side effects
Distressed about side effects
Prescription not filled or refilled at expected rate
Late stage of cancer
Poor physical status (ECOG 1 or over)
Provider relationship strained
No show for appointments and reluctance to
reschedule/Requesting a different provider
Significant other concerns about not following
treatment regimen
Prescription not refilled at expected intervals
Pill bottle contains more pills than it should
based on fill date (If it is the original bottle)
Taking additional unprescribed herbal or
"natural" substances
Tobacco, ETOH abuse, illegal drug use
Weekly/daily pill box contains unopened/unused
pills
Reluctance to accept a change in regimen
Preference to be "prescription free" or "all
natural" or other alternatives
English is not first language

Notes:
(referrals/interven
tions)

(PHQ-9, NCCN
scores represent
“Current
screening”)
Greater than 10
prescribed
medications?
Record # of meds
here and consider
consult:______
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Related cues: Knowledge
deficits including general
knowledge/limited English
proficiency/functional/Cogniti
ve/Psychological/Health
literacy/Untreated Vision or
Hearing Impairment/Memory
impairment/misconceptions
/Distrust

Uncontrolled Chronic
Illness:
Diabetes

o
o
o
o
o
o
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Reluctance, difficulty, or inability to read and/or
correctly explain written medication instructions
(on pill bottle or med list)
Medication not taken correctly
Identifies medications by color, size, and shape
but unable to explain what medications are, or
what they are for.
Has not filled prescription/reluctant to answer
questions about compliance with regimen
Significant other takes care of all paperwork
Known memory impairment

Signs/Symptoms:

Related Medication:

Sign/Symptom/Diagnoses

Related or possibly related
med

Hypertension/C
VD
Renal
Impairment
Sustained
uncontrolled
depression/Ment
al Illness
COPD
Unplanned Care:
Clinic Visit
Emergency
Room Visit
Hospitalization

Talking points:








Over 300 billion dollars spent on prescription drugs in 2015 (DC, 2017)
Mental health and non-communicable disease are expected to exceed 65% of the global burden of disease
in 2020; however 50% to 60% of patients (especially those with chronic diseases) are nonadherant to the
medicine prescribed (Lam & Fresco, 2015).
50% to 70% of prescriptions make it to the pharmacy, 48% to 66% come out of a pharmacy, 25% to 30%
are taken properly, and only 15% to 20% are refilled as prescribed (Millionhearts.hhs.gov, 2017).
Successful therapy with medication is key to combating challenges with public health in both developed
and developing countries. Therefore health care professionals and researchers need to do everything
possible to improve adherence to medication regimens (Lam & Fresco, 2015).
Definition of adherence: The World Health Organization definition of adherence: "the extent to which the
persons' behavior (including medication-taking) corresponds with agreed upon recommendations from a
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healthcare provider" and includes the initiation, continuation and discontinuation of the therapy as directed
(Lam & Fresco, 2015; WHO, 2003).
The CMS (Centers for Medicare and Medicaid Services) posted new measure information forms such as
the NQF 2468: Adherence to Oral Diabetes Agents for Individuals with Diabetes Mellitus. CMS will look
at databases of individuals prescribed at least two oral diabetes agents in 12 months. Specifically they will
look at adherence to the oral diabetes medications by checking if prescriptions are filled. In addition, this
measure is paired with two additional measures to check adherence to statins and ACEIs and ARBs for
individuals with diabetes (CMS, 2017).
A qualitative metasummary and triangulation with quantitative evidence provided forty-four factors
influencing adherence from 159 studies of patients with and without cancer. Factors included provider
relations, side effects, forgetfulness, and beliefs about medication necessity, establishing routines for taking
medication, social support, and ability to fit medications into lifestyle, cost, and medication knowledge.
Depression and negative expectations of results also had a negative effect on adherence (Irwin, & Johnson,
2015). This study was the most helpful in identifying the most prevalent barriers to adherence with multiple
studies confirming each one.

Barrier References and Notes:
1.Finances/
Social support

Cost can be a deterrent to filling prescriptions; patients do not fill their prescriptions about a
quarter of the time, and do not take them about half of the time (AMA, 2018).
Single marital status, lower income, and having more than 10 medications were significantly
associated with not filling medications. Reasons included cost by 23.5% of patients. Additional reasons
include lack of time to go to the pharmacy, medication not delivered or dispensed, and inability to afford
the medications (Wooldridge, Schnipper, Goggins, Dittus, & Kripalani, 2016).
Hanson, Habibi, Khamo, Abdou & Stubbings (2014) conducted a pharmacy study to examine
whether connecting patients with a team to help address the prohibitive expense of multiple sclerosis
drugs would improve adherence. It was in fact proven helpful, although the team concept involving
advanced providers was an expensive concept that would be difficult to reproduce and sustain. The
cancer center employs financial navigators, social workers, and nurse navigators who may provide a
more sustainable coordination of care.
Three major factors predict whether or not a patient can afford medication: 1. Insurance
coverage, 2. overall health and 3. Income. In addition individuals who make under $50,000/year in
income are more likely to skip doses or stop taking their medication than individuals with higher income
(NCPA, 2013).
Geography can be a significant hindrance for patients who live in rural areas, especially
without reliable internet service (Heath, 2017).
In a New York Times online journal article, Frakt (2017) cites systematic reviews and
randomized control trials analyzing several methods to address adherence such as electronic reminders,
pill organizers, and electronic reminder and feedback systems. The author concludes that reduced price,
or free medications are the only consistent predictor that patients will take and refill medication as
directed (Frakt, 2017). "For those with certain chronic conditions, extra help in affording medications can
reduce adverse events and hospitalizations
- One in five adults reported taking at least four prescription drugs with 55% taking at least
one. 35% of patients taking four or more prescription pills reported taking lower dosage or skipped doses
(and if uninsured did not fill the prescription) compared to 25% of those taking three or fewer. Income of
$40,000 a year or less was another predictive factor of lowering, skipping, or not filling a prescription
(KFF, 2017).
- 1084 adult patients at University of Pennsylvania and Pennsylvania Presbyterian hospitals
were surveyed to discover the issues they felt caused their readmission. Among the most common
reasons included low socioeconomic status (Medicaid or uninsured) driven barriers of obtaining and
adhering to medication regimens (Kangovi et al., 2012).
Irwin & Johnson (2015) cite cost or lack of insurance coverage was mentioned 26% of the
time, and social support was a reported factor of nonadherence 32% of the time in their meta-analysis of
qualitative research with triangulation to quantitative studies.
Single marital status is a significant predictor of nonadherence according to one study (Greer et
al., 2016).
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2. Depression,
Distress and/or
Anxiety

3. Medical
Concerns

4.
Behaviors/Lifesty
le
4. Behavioral and
Lifestyle Barriers
- Forgetting/Don't
think it's
needed/Didn't
"agree" to take
it/Don't like
taking it/ too
busy/Away from
home/no
established
routine
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Patients who are depressed or anxious are less likely to take their medications (AMA, 2018).
Patient fills out PHQ-2 followed (if indicated by PHQ-2 score) by the PHQ-9. A score of 15 or higher on
PHQ-9 indicates a moderately severe depression barring other causes such as thyroid disorder (American
Family Physician, 2012).
If a patient has a history of mental health disorders such as depression, anxiety, or addiction, he or she is
less likely to adhere to their medication regimen (Millionhearts.hhs.gov, 2017).
Greer et al. (2016) in a systematic review of adherence to oral chemotherapy agents reported that
depression played a significant role in nonadherence, with some rates dropping to about 50% at the fiveyear follow up.
Adjuvant endocrine therapy adherence was lower in women with depressive symptoms, especially in
younger women just starting endocrine therapy. Individuals with depression have greater non-adherence
than patients without depressive symptoms. In this study, women with lower adherence were also found
to have a shorter time to recurrence of their cancer, increased medical costs and worse quality of life
(Mausbach, Schwab & Irwin, 2015).
Long-term distress may be a predictor of non-adherence (Aikens, Trivedi, Aron, & Piette, 2015).
- The Oncology Nursing Society provides information gleaned from an extensive review of literature on
medication adherence. Their resource states that treatment of depression is found to be an intervention
that is likely to be effective (Spoelstra, & Sansoucie, 2015).
The greater the number of different medications prescribed and the higher the frequency, the more likely
that a patient will be nonadherant to their medication regimen (AMA, 2018). The relationship to the
provider is also a predictive factor in adherence. Advertisements, news coverage and stories can have a
negative effect and/or cause mistrust. Patients are less likely to fill their prescription if they do not trust
the prescriber (AMA, 2018)
"Mutually respectful collaboration with providers" is one key to improving adherence (CDC, 2017a). A
meta-analysis of qualitative research with triangulation to quantitative research revealed a 42% frequency
of provider relationship as a predictor of adherence in the qualitative literature. A positive relationship
facilitates adherence while a negative relationship does the opposite (Irwin, & Johnson, 2015).
Side effects were reason for stopping medication in 21% of self-reported reasons for nonadherence in a
national telephone survey of 1020 adults with chronic illness and four or more medications (NCPA,
2013). Side effects were found 40% of the time in the qualitative literature in a meta-analysis of research
regarding nonadherence (Irwin, & Johnson, 2015).
- A qualitative study of Turkish migrants with type 2 diabetes found that nonadherence may be impacted
by different beliefs about medications (Peeters et al., 2015).
- Barriers to adherence can start in the clinic or hospital setting due to medication reconciliation
discrepancies (Balling, Erstad, & Weibel, 2015).
-although questionnaires can be time prohibitive to administer there are some that can be effective for
assessing nonadherence. However interviewing patients is an easy, low-cost method to assess patient's
adherence. Although knowledge may not accurately reflect adherence, knowing that they will be asked
about medications by their provider may encourage adherence (Lam & Fresco, 2015).
As mentioned in the financial and social category, single marital status, lower income, and having more
than 10 medications were significantly associated with not filling medications. Reasons included cost by
23.5% of patients. Additional reasons include lack of time to go to the pharmacy, medication not
delivered or dispensed, and inability to afford the medications (Wooldridge, Schnipper, Goggins, Dittus,
& Kripalani, 2016).
Forgetting was the number one self-reported reason for nonadherence in a national telephone survey
(NCPA, 2013). However, additional research reviews of studies comparing reminder methods to control
groups revealed that this may not be as large of an impact as previously reported (Frakt, 2017).
Patients who express that they are tired of taking medications are showing a predicting sign that they are
nonadherant (Millionhearts.hhs.gov, 2017).
Frequency of forgetfulness was 38% and doubting necessity was 35% in a meta-analysis of research with
triangulation (Irwin, & Johnson, 2015). In the same study, pill burden is mentioned with 25% frequency
and regimen complexity 22% of the time.
Methods to encourage patient adherence recommended by the Oncology Nursing Society include
Reminder instruments such as calendars, pill diaries, pill boxes with compartments for time of day for
each day of the week, electronic reminders such as alarms, timers, smart phone apps, glowing or
electronic pill containers and medication dispensing machines (ONS, 2016).
As mentioned in the financial and social category, single marital status, lower income, and having more
than 10 medications were significantly associated with not filling medications. Reasons included cost by
23.5% of patients. Additional reasons include lack of time to go to the pharmacy, medication not
delivered or dispensed, and inability to afford the medications (Wooldridge, Schnipper, Goggins, Dittus,
& Kripalani, 2016).
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- Predictors of nonadherence include limited English language proficiency, low literacy, don't believe in
the benefits of medication or believe they are not necessary or even harmful (Millionhearts.hhs.gov,
2017).
- Patients who do not understand the purpose, side effects, or expected time before it is effective may
result in nonadherence. This is true in patients with chronic illness because there is often no obvious
result so the patient may think it is not doing anything for them and stop taking it (AMA, 2018).
- The Oncology Nursing Society review of literature recommendations suggest in 2014 there was not
enough information to establish education as an effective means of promoting adherence (Spoelstra, &
Sansoucie, 2015). However, an additional study published by the Oncology Nursing Society in 2015
cites medication knowledge was mentioned 25% of the time in an extensive meta-analysis of qualitative
studies triangulated with quantitative studies (Irwin, & Johnson, 2015).
-A Joint Commission study assessing the feasibility of a three-question literacy instrument states that
addressing health literacy is a national health priority and Standard PC.02.02.01 is cited "The hospital
effectively communicates to patients when providing care, treatment, and services" "Health literacy is the
degree to which individuals have the capacity to obtain, process, and understand basic health information
and services needed to make appropriate health decisions. It is a necessary skill for successful navigation
of the health care system, communication with providers, and management of chronic conditions.
However, an estimated 90 million adults in the United States have low health literacy,2 which is
associated with lower rates of preventive .care, poorer disease control, and greater mortality, as well as
increased health care utilization and costs.3,4 (Cawthon, Mion, Willens, Roumie & Kripalani, 2014).
Inability to read and understand directions, pill bottle labels may be due to small print, confusing medical
terms or abbreviations as well (CDC, 2017a).
-Patients with higher levels of education typically are correlated with better health, have had more health
education, and can advocate better for themselves (Heath, 2017).
Using 5th to 6th grade reading level with pictures and "teach-back" methods may help patients feel better
prepared for discharge and to care for themselves (Parr, 2017).
-A structured, nurse-led teaching program that included follow-up phone calls at set intervals had
encouraging results in lung cancer patients taking an oral chemotherapy drug (Boucher, Lucca, Hooper,
Pedulla, & Berry, 2015).
In a systematic review of randomized control trials it was proven that group psychoeducation was
effective in improving medication adherence in adults suffering from schizophrenia (Al-Batran, 2015).
-A study conducted by pharmacists at MD Anderson Cancer Center in Texas showed reduced
hospitalization when patients were contacted by a pharmacist within 30 days of discharge to have
adherence assessed, questions answered, and any discrepancies addressed (Patel, Phuoc, Bachler &
Atkinson, 2017).
- An additional pharmacist-driven study evaluated the impact of providing medications immediately
upon discharge to patients admitted to a psychiatric unit and found that this improved adherence to the
treatment regimen (Tomko et al., 2013). This is not feasible when a dispensing pharmacy is not readily
available. However it may be helpful to utilize this method if available in the future.
- 1084 adult patients were surveyed to discover the issues they felt caused their readmission. The most
common reasons included feeling unprepared for discharge and lack of social support. Low
socioeconomic status (Medicaid or uninsured) were more likely to report difficulty understanding and
executing discharge instructions (Kangovi et al., 2012).
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APPENDIX E: Letters of Support
Mrs Washburn,
Thank you for your interest in this project. We are happy to grant you permission to
work on this study and provide you any support you need. Please let me know how I can
assist you further.
Thanks,
Katie Kirby, MSN, RN, OCN, CMPE, NE-BC
Director of Practice Operations
Lynchburg and Southside Hematology Oncology
(434) 200-1492
(434) 401-5167
From: Donna Washburn
Sent: Tuesday, March 20, 2018 11:46 AM
To: Katie Kirby <Katie.Kirby@Centrahealth.com>; Carol Riggins <Carol.Riggins@Centrahealth.com>
Cc: Washburn, Donna (Nursing) <djwashburn@liberty.edu>
Subject: PERMISSION NEEDED PLEASE
Importance: High
Mrs. Carol Riggins
Managing Director
Centra Pearson Cancer Center
Administrative Suite
1701 Thomson Drive
Lynchburg, VA 24501
Mrs. Katie Kirby
Director
Centra Medical Oncology Clinic
Suite 200
1701 Thomson Drive
Lynchburg, VA 24501
3/20/2018

Dear Mrs. Riggins and Mrs. Kirby,

As a graduate student in the department at Liberty University, I am conducting an evidence-based
practice nursing research project as part of the requirements for a Doctorate of Nursing Practice. The
title of my study is, “Addressing barriers to medication adherence: An evidence-based screening
instrument validation study.” The purpose of the research is to find out if an evidence-based screening
instrument will help identify actionable barriers to successful medication adherence in patients who are
Medicare/Medicaid eligible. If after a retrospective review of medical records, it is found that the
screening instrument can in fact help identify actionable barriers. The screening instrument may then
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help navigators intervene and prevent unnecessary clinic visits, emergency room visits, and
hospitalizations, by connecting these individuals to available community resources, depending on the
barriers identified.
I am writing to request your permission to conduct the project using retrospective medical record data
from CMS/OCM patients who have received chemotherapy in the Centra Medical Oncology Clinic within
a year prior to IRB approval of the project. For this study, there will be no interaction with patients, no
consent or surveys of any kind, and no prospective data collection. I will require interaction with medonc staff, navigator staff, and OCM staff for assistance identifying OCM patients who are eligible for
review. This may be as simple as a printed report showing a list of potentially eligible patients for me to
screen. I have been screened and provided with Centra student intern identification and computer
access.
Following your written permission, I will be submitting the study to the Liberty University IRB, and
Centra IRB for approval.
Thank you for considering my request. If you choose to grant permission, please provide a signed
statement on Centra letterhead indicating your approval, or respond by e-mail
to djwashburn@liberty.edu.
Thank you
Donna Washburn MSN, RN, CNS, ACNS-BC, AOCNS
434-426-1278
djwashburn@liberty.edu

Regards,
Donna
Donna Washburn MSN, RN, CNS, ACNS-BC, AOCNS
Clinical Nurse Specialist
Director Professional Clinical Practice
Centra Health
Office: 434-200-3296
Our Mission: Excellent Care for Life
Our Vision: To be the Most Trusted Provider of Innovative Healthcare
Our Nurses: Nurses have been ranked the most trusted profession 15 years in a row

Electronic Privacy Notice. This e-mail, and any attachments, contains information that is, or may be, covered by electronic
communications privacy laws, and is also confidential and proprietary in nature. If you are not the intended recipient, please
be advised that you are legally prohibited from retaining, using, copying, distributing, or otherwise disclosing this
information in any manner. Instead, please reply to the sender that you have received this communication in error, and then
immediately delete it. Thank you in advance for your cooperation.
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You have my permission.
Please keep us updated.
Carol Riggins, RN, MSN, GCNS-BC, OCN
Managing Director,
Alan B. Pearson Regional Cancer Center
Lynchburg, VA 24501
434-200-6601
Carol.Riggins@centrahealth.com

Electronic Privacy Notice. This e-mail, and any attachments, contains information that is, or may be, covered by electronic
communications privacy laws, and is also confidential and proprietary in nature. If you are not the intended recipient, please
be advised that you are legally prohibited from retaining, using, copying, distributing, or otherwise disclosing this
information in any manner. Instead, please reply to the sender that you have received this communication in error, and then
immediately delete it. Thank you in advance for your cooperation
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APPENDIX G: SPSS Coding Key and Comments
SPSS Variables

Definition and Scoring System

Notes

Last three numbers of MRN, then subject

ie: 1230001

(expanded)
ID

number using four placeholders I.e. 0001 to
0300
Gender

1 - male, 2 = female

BirthYear

Year of birth

CurrentMC_MA

Medicare/Medicaid Patient, 1 = negative,

Current intervention to provide insurance and

2 = Positive with documented intervention,

financial counseling on initial visit prior to

3 = Positive without documented

treatment

Intervention
CurrentPHQ9

PHQ-9 Depression Score 15 or higher,

Current Scoring Tool in use, also integrated

(Independent variable:

1 = negative, 2 = Positive with documented

into W-BMA Depression, Distress, and

"Current Screening")

intervention, 3 = Positive without

Anxiety category (Part of independent

documented Intervention

variable for study called: "Current Screening")

CurrentNCCNDistress

NCCN Distress Score 4 or higher,

current Scoring Tool in use, also integrated

(Independent variable:

1 = negative, 2 = Positive with documented

into W-BMA Depression, Distress, and

"Current Screening")

intervention, 3 = Positive without

Anxiety category (Part of independent

documented Intervention

variable for study called: "Current Screening")

WBMA1_Fin_Soc

Category 1, Financial and Social Risk,

Washburn Barriers to Medication Adherence

(Independent variable "W-

1 = negative, 2 = Positive with documented

Risk Assessment Tool - Risk Factors

BMA Screen" or "W-BMA

intervention, 3 = Positive without

associated with financial and social barriers

Instrument")

documented Intervention

(Part of independent variable usually referred
to as: "W-BMA Screen" or "W-BMA
Instrument")
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WBMA2_Dep_Dis_Anx

Category 2, Depression, Distress, Anxiety

Washburn Barriers to Medication Adherence

(Independent variable "W-

Risk, 1 = negative, 2 = Positive with

Risk Assessment Tool - Risk Factors

BMA Screen" or "W-BMA

documented intervention, 3 = Positive

associated with depression, distress, and

Instrument")

without documented Intervention

anxiety including PHQ-9 and NCCN Distress
scores (Part of independent variable usually
referred to as: "W-BMA Screen" or "W-BMA
Instrument")

WBMA3_MedRelCon

Category 3, Medical Related Concerns,

Washburn Barriers to Medication Adherence

(Independent variable "W-

1 = negative, 2 = Positive with documented

Risk Assessment Tool - Risk Factors

BMA Screen" or "W-BMA

intervention, 3 = Positive without

associated with medical related barriers (Part

Instrument")

documented Intervention

of independent variable usually referred to as:
"W-BMA Screen" or "W-BMA Instrument")

WBMA4_Beh_Lifestyle

Category 4, Behavioral and lifestyle,

Washburn Barriers to Medication Adherence

(Independent variable "W-

1 = negative, 2 = Positive with documented

Risk Assessment Tool - Risk Factors

BMA Screen" or "W-BMA

intervention, 3 = Positive without

associated with behavior and lifestyle barriers

Instrument")

documented Intervention

(Part of independent variable usually referred
to as: "W-BMA Screen" or "W-BMA
Instrument")

WBMA5_Educ

Category 5 Educational, 1 = negative,

Washburn Barriers to Medication Adherence

(Independent variable "W-

2 = Positive with documented intervention,

Risk Assessment Tool - Risk Factors

BMA Screen" or "W-BMA

3 = Positive without documented

associated with educational barriers (Part of

Instrument")

Intervention

independent variable usually referred to as:
"W-BMA Screen" or "W-BMA Instrument")

Diabetes_uncontolled

Uncontrolled Diabetes, Defined as blood

Uncontrolled chronic illness assessment for

glucose over 140 without a formal diabetes

sensitivity testing. All uncontrolled illness

diagnoses, or glucose over 180 with DMII

grouped into one variable for primary

diagnoses or over 130 if documented fasting.

statistical tests.

1 = Negative and no med, 2 = Negative and
on associated med, 3 = Positive and no
prescribed medication, 4 = Positive and has a
prescribed medication
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Uncontrolled Hypertension, Defined as BP

Uncontrolled chronic illness assessment for

greater than 140 systolic, or 90 diastolic in

sensitivity testing. All uncontrolled illness

two or more visits without resolution to

grouped into one variable for primary

130/80 or below. 1 = Negative and no med,

statistical tests.

2 = Negative and on associated med,
3 = Positive and no prescribed medication,
4 = Positive and has a prescribed medication
Renal_Imp_uncontrolled

Uncontrolled Renal Illness defined as an

Uncontrolled chronic illness assessment for

abnormal GFR grade 2 or worse, or

sensitivity testing. All uncontrolled illness

Creatinine Grade 2 or worse sustained over 2

grouped into one variable for primary

or more consecutive visits, 1 = Negative and

statistical tests.

no med, 2 = Negative and on associated med,
3 = Positive and no prescribed medication,
4 = Positive and has a prescribed medication
(Note: this is a common adverse event
associated with cancer treatment)
Dep_Mental_uncontrolled

Uncontrolled depression or mental illness,

Uncontrolled chronic illness assessment for

defined as documented in chart, 1 = Negative

sensitivity testing. All uncontrolled illness

and no med, 2 = Negative and on associated

grouped into one variable for primary

med, 3 = Positive and no prescribed

statistical tests.

medication, 4 = Positive and has a prescribed
medication
COPD_uncontrolled

Event_Unplanned_Clinic

Uncontrolled COPD, 1 = Negative and no

Uncontrolled chronic illness assessment for

med, 2 = Negative and on associated med,

sensitivity testing. All uncontrolled illness

3 = Positive and no prescribed medication,

grouped into one variable for primary

4 = Positive and has a prescribed medication

statistical tests.

Unplanned Outpatient Clinical Visit, 1 =

Event Assessment for potential correlation

negative or visit was unrelated or probably

with severity of uncontrolled illness and future

unrelated to possible medication

measurable financial implications of non-

nonadherence or uncontrolled illness (# 1 or

adherence.

2 negative in uncontrolled illness section),
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2 = Positive and possibly or definitely related
to possible medication nonadherence and/or
uncontrolled illness (# 3 or 4 positive
responses in uncontrolled illness section)
Event_ER

Emergency Room Visit with or without

Event Assessment for potential correlation

hospitalization, 1 = negative or visit was

with severity of uncontrolled illness and future

unrelated or probably unrelated to possible

measurable financial implications of non-

medication nonadherence or uncontrolled

adherence.

illness (# 1 or 2 negative in uncontrolled
illness section), 2 = Positive and possibly or
definitely related to possible medication
nonadherence and/or uncontrolled illness (# 3
or 4 positive responses in uncontrolled illness
section)
Event_Hospital

Hospitalization (including observation),

Event Assessment for potential correlation

1 = negative or hospitalization was unrelated

with severity of uncontrolled illness and future

or probably unrelated to possible medication

measurable financial implications of non-

nonadherence or uncontrolled illness (# 1 or

adherence.

2 negative in uncontrolled illness section),
2 = Positive and possibly or definitely related
to possible medication nonadherence and/or
uncontrolled illness (# 3 or 4 positive
responses in uncontrolled illness section)
OSS_Full_Support

Oncology Support Services providing full

Oncology Support Services providing full

support. 1 = yes, 2 = no

support throughout patient treatment to
address known issues (not including "meet
and greet" and initial pretreatment financial
counseling) Full support focused on Navigator
involvement, but includes Social Worker,
Financial Support, Palliative Care.
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The number of prescribed meds - includes

Excluded: Chemotherapy treatment and

OTC meds recommended by provider

medications used to pretreat the patient in the
clinic prior to chemo administration. Also
excluded: OTC medications not recommended
by provider including allergy and cold relief
remedies, vitamins or herbal supplements,
pain relief medications and sleep aides

Free Text Comments

